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ABSTRACT
The need for residual life analysis arises in many fields including medicine and life testing.
For instance, in medicine, a clinician and a patient would be interested in knowing by
how long a new drug can extend the life span of that patient. Problems in remaining
life time after surviving up to a certain time are often framed and addressed statistically
in terms of mean, hazard rate or quantile. The quantile approach enjoys some practical
advantages over the other approaches such as robustness, ease of interpretation, and existence.
Most of the methodological work on quantile residual life in the literature has been semi-
parametric or non-parametric. However, parametric approaches are expected to be optimal
or asymptotically efficient under a correct specification of the model. Furthermore, the
parametric approach does not require nonparametric estimation of the probability density
function of the underlying distribution under informative or noninformative censoring to
evaluate the variance of the quantile estimator. In this dissertation, parametric inference
procedures for the quantile residual life under competing and non-competing risks settings
are developed for the one-sample, two-sample and regression cases. We adopt the accelerated
failure time (AFT) framework to incorporate covariates for the regression case. The finite
sample properties of the proposed methods are studied through extensive simulations. The
simulation results indicate that the proposed methods perform well. The proposed methods
are applied to a breast cancer data set.
PUBLIC HEALTH SIGNIFICANCE: The results established in this dissertation will provide
new parametric methods to researchers and investigators in public health who conduct quantile
v
residual life analysis, which will facilitate efficient communication between researchers and
stakeholders regarding the efficacy of new interventions.
Keywords: Quantile residual life, Parametric, Breast Cancer, Competing Risk, Accelerated
Failure Time.
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1.0 INTRODUCTION
Residual life analyses are used in many fields, including medicine and life-testing. These
analyses have been undertaken via mean, quantile and hazard-based approaches. The quantile
approach has some theoretical and practical advantages over the other approaches. Indeed,
quantile inference methods are more interpretable than hazard based approaches. Quantiles
are more stable to tail behavior than means are. Quantiles always exist whereas means many
not exist.
Most of the proposed inference procedures for quantile residual life in the literature are
non-parametric or semi-parametric. These include one-sample and two-sample procedures for
quantile residual life under competing and non-competing risks by Jeong et al. (2008), and
Jeong and Fine (2013); and a semi-parametric regression method for inference on quantile
residual life by Jung et al. (2009) .
Comparatively, there has been less work on the parametric inference method for quantile
residual life. This is despite the fact that parametric procedures are expected to result in
a gain in efficiency, simplicity in inference as there is no need for non-parametric density
estimation, and simplicity in analysis and interpretation (Koenker and Bassett, 1978; Lin
and Spiekerman, 1996).
Parametric procedures for quantile residual life in the literture include a one-sample
method and regresson method for inference on the cumulative incidence function by Jeong and
Fine (2006, 2007). More recently, Lee and Fine (2011) proposed one-sample and two-sample
parametric inferential procedures for cause-specific quantile life time.
1
    In this dissertation, we will develop parametric inferential procedures for the quantile 
residual life time under non-competing and competing risks scenarios. Three settings will be 
covered: a single sample, a two sample and a regression setting. The procedures will be 
illustrated numerically and via simulations using the Weibull distribution. The Weibull 
distribution is a flexible and widely used parametric survival model.
The dissertation is organized as follows. In Chapter 2, a brief review of the literature is 
given. In Chapter 3, likelihood based quantile residual life inference procedures for one-sample, 
two-sample and regression cases under non-competing risks setting are developed. The results 
are illustrated with simulations and applied to a real data set. In Chapter 4, the results in 
Chapter 3 are generalized to the competing risks setting. The results are also described by 
simulations and applied to a real data set.
2
2.0 LITERATURE REVIEW
We briefly review recent works on inference procedures for the quantile (residual) life time.
Non-parametric procedures include that of Jeong et al. (2008), Jeong and Fine (2013)
and Jung et al. (2009). Jeong et al. (2008) proposed one-sample and two-sample inferential
procedure for median residual life time for non-competing risks data. Jeong and Fine (2013)
extended this procedure to a method for quantile residual life time and competing risks data.
Jung et al. (2009) proposed a semi-parametric regression method for inference on quantile
residual life time.
Parametric procedures include a one-sample method and regression method for inference
on cumulative incidence function by Jeong and Fine (2006, 2007). Since the cumulative
incidence function is the inverse of the cause-specific quantile life life time, these methods
are related to inference on quantile life time. More recently, Lee and Fine (2011) proposed
a parametric inferential procedure for cause-specific quantile life time. All of the above
parametric methods are based on the asymptotic properties of the maximum likelihood
estimator (MLE) ((in particular, consistency and asymptotic normality)) and the delta
method.
In this dissertation we use a parametric approach to develop one-sample, two-sample and
regression parametric procedures for the quantile residual life time in both non-competing
risks and competing risks setting. When the quantile residual life does not have a closed-form
representation, which can arise even in simple settings, its estimation is not obvious. We
propose a simple numerical scheme to estimate it.
3
3.0 NON-COMPETING RISKS
Much of survival analysis deals with the analysis of failure data in which there is a well-defined
and single failure type that may be subject to a censoring process that is unrelated to the
failure process. We will term this type of failure process the non-competing risks setting.
This is in contrast to the competing risks setting, where there are two or more distinct failure
types in addition to a random censoring process (Prentice et al., 1978).
In this chapter, likelihood-based inference procedures for the quantile residual life are
derived for the non-competing risks setting. Point estimators and asymptotic variance
formulas for the quantile residual life time are given. The procedures are illustrated using
simulations and real data analysis. Results for the one-sample, two-sample, and regression
cases are presented in Sections 3.2, 3.3, and 3.4, respectively.
We review some basic concepts from survival analysis. These concepts are used in
subsequent sections.
3.1 INTRODUCTION
Suppose T ≥ 0 is failure time random variable with an absolutely continuous distribution
function F (t). For example, T can be time to death from diagnosis of a breast cancer patient.
Let f(t) = dF (t)
dt
and S(t) = 1− F (t) denote the density and survival functions, respectively,
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of T . The hazard function h(t) of T is defined as
h(t) = lim
∆t→0
P [t ≤ T < t+ ∆t|T ≥ t]
∆t
=
f(t)
S(t)
, (3.1.01)
whereas its cumulative hazard function H(t) is given by
H(t) =
∫ t
0
h(u)du.
The hazard function quantifies the rate of failure at time t among subjects that are still at
risk of failure at time t.
When F is a proper distribution function, i.e., F (∞) = 1, there is a 1-1 correspondence
among the different survival quantities. We will point out two such correspondences that we
will use later. The survival function S(t) can be written as S(t) = exp(−H(t)); thus, F has
the following equivalent representations,
F (t) =
∫ t
0
f(u) du =
∫ t
0
S(u)h(u) du
=
∫ t
0
exp(−H(u))h(u) du, (3.1.02)
where we have used Equation 3.1.01 in the second equality. Equation 3.1.02 suggests that F
can be specified in variously equivalent ways. The last representation in the equation (3.1.02)
indicates that the hazard function completely determines the distribution function.
Given F , the τ -quantile of the distribution of T , Q(τ), is defined as
Q(τ) = F−1(τ), τ ∈ (0, 1);
and the τ -quantile residual or remaining life time at time t0, Qt0(τ), is defined as
Qt0(τ) = F
−1
t0
(τ), τ ∈ (0, 1);
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where Ft0(t) denotes the distribution function of T − t0|T > t0. The τ -quantile residual life
at time t0, Qt0(τ), can be written in terms of Q(τ). Indeed, by the definition of τ -quantile
residual life time ,
Ft0(t) = P (T − t0 ≤ t | T ≥ t0)
=
P (t0 < T ≤ t+ t0)
P (T > t0)
.
This implies
Ft0(t) =
F (t+ t0)− F (t0)
1− F (t0) , (3.1.03)
for t ≥ 0. Thus,
Qt0(τ) = F
−1(τ(1− F (t0)) + F (t0))− t0 (3.1.04)
where 0 < τ < 1. Equation 3.1.04 is equivalent to:
Qt0(τ) = Q(τ(1− F (t0)) + F (t0))− t0 (3.1.05)
Parametric inference on Qt0 (Equations 3.1.04) can be undertaken by making a parametric
assumption about Ft0(t) or on F (t) (or equivalently on h(t)). The latter approach is used as
it provides a more flexible generalization to the competing risks setting. The dependency of
F on the unknown parameter vector θ can be made more explicit by writing it as F (t; θ). In
the regression setting, we can write it as F (t; θ, Z) to indicate its dependency on θ and the
baseline covariate vector Z as well. However, for notational convenience, we will sometimes
suppress the dependency of the survival quantities on their arguments, if no confusion may
arise.
Finally, we will assume that regularity conditions needed to make the asymptotics work
hold. In particular, we will assume that Qt0(τ) is differentiable with respect to θ.
6
3.2 ONE SAMPLE
In this section, a parametric inference on the true residual quantile life time based on a random
sample of right-censored data from a homogeneous population is considered. Section 3.2.1
presents the basic results, Section 3.2.2 considers application of the results to the Weibull
model, Section 3.2.3 presents simulation results using the Weibull model, and Section 3.2.4
applies the results to real data set.
3.2.1 Theory
Let {Ti}ni=1 be i.i.d failure times with distribution function F (.; θ) assumed to be known
up to an unknown parameter θ = (θ1, θ2, . . . , θp), and {Ci}ni=1 be i.i.d censoring times with
distribution function G(.). G is assumed not have any parameter in common with F . Thus,
we are making a parametric assumption about F . To ensure random censorship, we assume
the failure times and censoring times are mutually independent. We only observe {(Xi, δi)}ni=1,
where
Xi = min{Ti, Ci} and δi = I(Ti ≤ Ci).
These are right-censored data, the most common form of censored data in clinical trial and
biomedical studies (Lagakos, 1979). The goal is to make inference on Qt0 , the true quantile
residual life time at time t0,
Qt0(τ ; θ) = F
−1(τ(1− F (t0; θ)) + F (t0; θ))− t0 (3.2.11)
using the observed data. In particular, we are interested in point and large sample interval
estimates of Qt0 .
While inference on Qt0 can be made in other ways, likelihood based inference provides
asymptotically optimal estimates when the assumed model is correct (Boos and Stefanski,
2013). The delta method, along with the asymptotic property of the MLE, are used to derive
likelihood-based point and confidence interval estimators.
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Under random censorship, the contribution of (Xi, δi = 1) to the likelihood is f(Xi; θ)
and that of (Xi, δi = 0) is S(Xi; θ). Thus, the likelihood function for the observed data is:
L(θ | {(Xi, δi)}ni=1) =
n∏
i=1
f(Xi; θ)
δiS(Xi; θ)
1−δi
=
n∏
i=1
h(Xi; θ)
δiS(Xi; θ) (by Equation 3.1.01).
The log-likelihood in terms of the latter form of the likelihood has the form:
`n(θ) =
n∑
i=1
δi lnh(Xi; θ) +
n∑
i=1
lnS(Xi; θ).
The score function,
U(θ) =
∂
∂θ
`n(θ) (3.2.12)
contains the elements:
∂
∂θj
`n(θ) =
n∑
i=1
{
δi
1
h(Xi; θ)
∂
∂θj
h(Xi; θ) +
1
S(Xi; θ)
∂
∂θj
S(Xi; θ)
}
j = 1, · · · , p.
A maximum likelihood estimator (MLE) of θ, θˆ, is any solution of U(θ) = 0. Under regularity
conditions, the MLE is unique and consistent (Borgan, 1984).
Since Qt0(τ ; θ) is a differentiable function of θ, a consistent estimator of it is,
Qˆt0(τ ; θ) = Qt0(τ, θˆ) = F
−1(τ(1− F (t0; θˆ)) + F (t0; θˆ))− t0. (3.2.13)
The asymptotic distribution of Qˆt0(τ ; θ) follows by the multivariate-version of the delta
method. The application of the delta method requires that θˆ be consistent for θ and
asymptotically normally distributed. By the asymptotic properties of the MLEs (Borgan,
1984), as n−→∞,
√
n(θˆ − θ) d−→ N(0, I−1(θ)) (3.2.14)
where I−1(θ) is the inverse of the expected information matrix,
I(θ) = −E
{
1
n
∂2
∂θ∂θT
`n(θ)
}
.
The expected information matrix, even under random censorship, depends on the unknown
censoring distribution and could be difficult or impossible to calculate even when the censoring
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distribution is known (Kalbfleisch and Prentice, 2002). As a result, in applications the expected
information matrix is replaced by its consistent estimator, the sample information matrix,
I(θ) = − ∂
2
∂θ∂θT
`n(θ).
A consistent estimator of I−1(θ) is nI−1(θˆ), where I−1(θˆ) is the inverse of the sample
information matrix evaluated at the MLE of θ. Now, applying the delta method yields the
asymptotic distribution of Qˆt0 ,
√
n(Qˆt0 −Qt0) d−→ N(0, nAvar(Qˆt0)) (3.2.15)
where
Avar(Qˆt0) =
1
n
{
∇θˆQt0(τ ; θˆ)|θˆ=θ
}T
I−1(θ)
{
∇θˆQt0(τ ; θˆ)|θˆ=θ
}
. (3.2.16)
For inference (testing and confidence intervals) on the quantile residual life time, the unknown
quantities in Equation 3.2.16 are estimated by their consistent estimators. Hence, a consistent
estimator for the asymptotic variance of the quantile residual life estimator is:
̂Avar(Qˆt0) =
{
∇θˆQt0(τ ; θˆ)|θˆ=θˆ
}T
I−1(θˆ)
{
∇θˆQt0(τ ; θˆ)|θˆ=θˆ
}
. (3.2.17)
Using the point estimate Qˆt0 and the estimator of its asymptotic variance, Wald-type
approximate tests and confidence intervals (CIs) can be constructed in the usual way. An
approximate two-sided 100(1− α)% Wald confidence interval(CI) for Qt0(τ ; θ) is:(
Qˆt0(τ ; θ)± z1−α/2
√
̂Avar(Qˆt0)
)
. (3.2.18)
In the subsequent sections, we will consider the application of the above result to the the
Weibull distribution.
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3.2.2 Application to the Weibull Model
We will use the two-parameter Weibull model for simulations and data analyses throughout
this dissertation. Some of its basic properties are briefly reviewed here. There are differ-
ent equivalent parametrization of the two-parameter Weibull. We will use the following
parametrization of it:
F (t) = 1− exp(−λtα), (3.2.21)
with shape parameter α > 0 and scale parameter λ > 0. Its survival function is given by
S(t) = exp(−λtα),
and its hazard function is given by,
h(t) = αλtα−1,
with α > 1, α < 1, and, α = 1 corresponding to increasing, decreasing and constant hazard,
respectively. This flexibility, along with the simplicity of the Weibull model, makes it a
popular model for parametric modeling. The Weibull distribution is the only parametric
distribution that has both the accelerated failure time and proportional hazard representations
(Klein and Moeschberger, 2003).
The likelihood of right-censored data {(Xi, δi)}ni=1 based on Weibull failure times under
random censorship is:
L(α, λ|{(Xi, δi)}ni=1) = exp
(
−λ
n∑
i=1
Xi
)
λ
∑n
i=1 δi .
Thus, its log-likelihood is of the form:
`n(α, λ) = (lnα + lnλ)
n∑
i
δi + (α− 1)
n∑
i=1
δi ln(Xi)− λ
n∑
i=1
Xαi .
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The score vector, U(α, λ), has the components:
Uα(α, λ) =
∂
∂α
`n(α, λ) =
∑n
i=1 δi
α
+
n∑
i
δi ln(Xi)− λ
n∑
i=1
Xαi ln(Xi)
Uλ(α, λ) =
∂
∂λ
`n(α, λ) =
∑n
i=1 δi
λ
−
n∑
i=1
Xαi ln(Xi).
The maximum likelihood estimator (MLE) of α and λ is the solution of the score vector
equation: U(α, λ) = (Uα(α, λ), Uλ(α, λ)) = 0. Thus, the MLE of α, αˆ, is a solution to the
following non-linear equation:
n∑
i=1
δi + α
n∑
i=1
δi ln(Xi)− α
( n∑
i=1
δi
)( n∑
i
Xαi
)−1 n∑
i=1
Xαi ln(Xi) = 0.
The MLE of λ can be expressed in terms of the MLE of α as:
λˆ =
∑n
i=1 δi∑n
i=1X
αˆ
i
.
The sample information matrix contains the following entries:
I(α, λ) =
α2∑ni=1 δi + λ∑ni=1Xαi (ln(Xi))2 ∑ni=1Xαi ln(Xi)∑n
i=1 X
α
i ln(Xi)
∑n
i=1 δi
λ2
 .
The MLE of the quantile residual life time function for the Weibull distribution at t0, Qˆt0 , is:[
tαˆ0 − λˆ−1 ln(1− τ)
]1/αˆ
− t0. (3.2.22)
The gradient vector of the MLE of the quantile residual life function,∇Qˆt0 , contains the
following components,
∂
∂αˆ
Qt0(τ ; αˆ, λˆ) = αˆ
−2(tαˆ0 − λˆ−1 ln(1− τ))1/αˆ
{
αˆtαˆ0 ln(t0)
[tαˆ0 − λˆ ln(1− τ)]
− ln[tαˆ0 − λˆ ln(1− τ)]
}
∂
∂λˆ
Qt0(τ ; αˆ, λˆ) = αˆ
−1λˆ−2[tαˆ0 − λˆ−1 ln(1− τ)]−1+1/αˆ ln(1− τ),
where we have used the convention tαˆ0 ln(t0) = 0 for t0 = 0 in the first equation.
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The estimated asymptotic variance of the MLE of the quantile residual life time function
has the form,
̂Avar(Qˆt0) = n
{
∇Qˆt0(τ ; αˆ, λˆ)
}T
I(αˆ, λˆ)−1
{
∇Qˆt0(τ ; αˆ, λˆ)
}
. (3.2.23)
By specializing the above discussion to the Weibull(1, λ), which is the exponential distribution
with scale parameter, λ, we get
Qˆt0(τ) =
[− ln(1− (τ(1− exp(−λˆt0)) + 1− exp(−λˆt0)))
λˆ
]
− t0
which simplifies to:
− ln(1− τ)
λˆ
.
The above expression is free of t0. Thus, the quantile and quantile residual life functions of
the exponential distribution are identical. This is due to the memory-less property of the
exponential distribution. Plugging 1 for αˆ and
∑n
i=1 δi∑n
i=1Xi
for λˆ in Equation 3.2.23, we obtain the
asymptotic variance of the quantile residual life estimator for the exponential distribution,
̂Avar(Qˆt0) =
[
ln(1− τ)
λˆ2
]
λˆ2∑n
i=1 δi
[
ln(1− τ)
λˆ2
]
=
(
ln(1− τ)
n∑
i=1
Xi
)2( n∑
i=1
δi
)−3
,
which is again free of t0.
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3.2.3 Simulation Study
We conducted a series of simulation studies to examine the performance of the proposed
method. The censoring proportion was set at 0.1. To simulate different failure time sce-
narios, we generated failure times from two Weibull distributions: Weibull(2, 0.5) and
Weibull(2, 0.25), where Weibull(α, λ) is the Weibull distribution with shape parameter α
and scale parameter λ. Censoring times were generated, respectively, from Unif(0, 5.5048),and
Unif(0, 12.5331) to get the desired level of censoring. For each failure time scenario, we
simulated N = 5000 data sets of sample sizes n = 400 and n = 100. Two quantile levels
τ = 0.25 and τ = 0.5, and two time points t0 = 0 and t0 = 1 were considered. All simulations
and data analyses in this section and throughout this dissertation were performed using R
statistical software.
Simulation results for the one-sample case are presented in Tables 3.2.1-3.2.2. In each
of the tables, the estimated quantile residual life time (Qˆt0), estimated asymptotic variance
( ̂Avar(Qˆt0)), empirical variance (
̂var(Qˆt0)), empirical bias (B̂ias), empirical MSE (M̂SE),
and 95% empirical coverage probability (CP ) are shown.
The Monte Carlo variance estimates and asymptotic variance estimates are similar across
all the simulation settings, suggesting that the asymptotic variance formula works well.
Coverage probability appears to be at the nominal-level. The quantile residual life time
estimates are unbiased and the empirical MSEs are small.
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Table 3.2.1: One-sample simulation result, Weibull(α = 2, λ = 0.5)
n t0 τ
̂Avar(Qˆt0)
̂var(Qˆt0) B̂ias M̂SE CP
400 0 0.25 0.001 0.001 0.001 0.001 0.952
0.50 0.001 0.001 0.001 0.001 0.952
1 0.25 0.000 0.000 0.000 0.000 0.944
0.50 0.001 0.001 -0.000 0.001 0.945
100 0 0.25 0.004 0.004 0.004 0.004 0.945
0.50 0.005 0.005 0.001 0.005 0.943
1 0.25 0.001 0.001 -0.000 0.001 0.944
0.50 0.003 0.002 -0.002 0.002 0.941
Table 3.2.2: One-sample simulation result, Weibull(α = 2, λ = 0.25)
n t0 τ
̂Avar(Qˆt0)
̂var(Qˆt0) B̂ias M̂SE CP
400 0 0.25 0.002 0.002 0.001 0.002 0.948
0.50 0.003 0.003 0.000 0.003 0.949
1 0.25 0.000 0.000 0.000 0.000 0.950
0.50 0.001 0.001 -0.000 0.001 0.948
100 0 0.25 0.002 0.002 0.002 0.002 0.949
0.50 0.003 0.003 0.001 0.003 0.949
1 0.25 0.000 0.000 0.001 0.000 0.947
0.50 0.001 0.001 0.001 0.001 0.946
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3.2.4 Data Analysis
Breast cancer survival data from the B-04 randomized trial run by the National Surgical
Adjuvant Breast and Bowel Project (NSABP) will be used to apply the proposed methods to
real data. This study was initiated in 1971 to investigate the effectiveness on survival of three
breast cancer surgery procedures: radical mastectomy, total mastectomy without radiation
therapy, and total mastectomy with radiation therapy. Participants in the study were 1765
women with primary operable breast cancer. At the beginning of the study, the patients were
assessed for the presence or absence of clinical nodal involvement in their cancer and were,
accordingly, stratified as clinically node positive or negative patients. 1079 of the patients
were found to be clinically node positive and 586 were found to be clinically node negative.
The radical and less extensive surgeries were compared within each nodal group. A major
result of the study reported in Fisher et al. (1977) and confirmed again in a later analysis
reported in Fisher et al. (2002) was that there was no difference among the three treatments
in their effects on various survival endpoints including overall survival.
For the data analyses in this chapter, we will use death from all causes (breast cancer or
other causes) as the survival outcome for the non-competing risks analysis. For the one-sample
analysis, we will perform separate quantile residual life analysis for the two nodal groups.
For the two-sample analysis, we will compare the quantile residual life of the two groups. For
the regression analysis, we will perform quantile residual life analysis using age (year), nodal
status and tumor size (mm) as covariates.
Summary statistics on the analysis variables considered in this chapter are presented in
Table 3.2.3. Due to missingness in the variable node type indicator variable, 66 subjects
were excluded from the analysis. Node positive patients have higher mortality than node
negative patients. Node positive patients tend to die earlier than node negative patients. The
observed censoring proportion is about 0.23. The median age at baseline is 55 years for node
positive patients and 57 years for node negative patients. Node positive patients have higher
median tumor size than node-negative patients.
For the one-sample residual life analysis, we fitted separate Weibull models to the survival
data for the node negative and node-positive patient groups. The quantile residual life time
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Table 3.2.3: Summary statistics on mortality, observed time, age, tumor size by node status
Node n Death Median Time Median Age Median Tumor Size
Positive 561 0.84 9.58 55.00 32.00
Negative 1038 0.74 12.72 57.00 30.00
All 1599 0.77 11.62 56.00 30.00
for each group was estimated at four time points t0 = 0, 2, 4, 6 and three quantile levels
τ = 0.1, 0.2, 0.5. The results for these analysis are shown in Table 3.2.4 for the node-positive
patients and in Table 3.2.5 for the node-negative patients. Each table presents point estimates
of the quantile residual life, estimate of the asymptotic variance of the quantile residual life
estimate, and 95% confidence interval estimate (CILL for lower limit and CIUL for upper
limit) of the quantile residual life at four time points t0 = 0, 2, 4, 6 and three quantile levels
τ = 0.1, 0.2, 0.5.
The results in both tables indicate that quantile residual life times do not seem to vary
much with time. The MLE for the fitted Weibull model for the node-positive group was
(αˆ = 0.93, λˆ = 0.11); and for that of the node-negative group was (αˆ = 1.07, λˆ = 0.047). The
αˆ s for both estimated models are close to 1, suggesting that the fitted model might not be
“far” from the exponential model and this might explain the lack of appreciable dependency
of quantile residual life estimates on time points from both models. The median residual
life estimates (for τ = 0.5) in Table 3.2.4 and Table 3.2.5 are within reasonable range of the
non-parameteric median residual life estimates reported in Table 3 of Jeong et al. (2008).
The plausibility of the fitted Weibull models was checked by comparing them with
Kaplan-Meier(KM) curves. Quantile-comparisons for the fitted and KM models are shown in
Figure 3.2.1 for the positive patient group and Figure 3.2.2 for the negative patient group. It
appears that the assumed Weibull models do not show significant lack of fit.
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Table 3.2.4: Quantile residual life analysis for node positive patients
t0 τ Qˆt0
̂Avar(Qˆt0) CILL CIUL
0 0.1 0.992 0.012 0.777 1.208
0.2 2.234 0.035 1.865 2.602
0.5 7.604 0.170 6.796 8.413
2 0.1 1.151 0.003 1.036 1.267
0.2 2.477 0.015 2.239 2.716
0.5 8.019 0.153 7.253 8.786
4 0.1 1.203 0.003 1.093 1.313
0.2 2.573 0.015 2.335 2.811
0.5 8.229 0.180 7.397 9.060
6 0.1 1.236 0.004 1.119 1.354
0.2 2.637 0.017 2.380 2.895
0.5 8.382 0.214 7.474 9.289
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Table 3.2.5: Quantile residual life analysis for node negative patients
t0 τ Qˆt0
̂Avar(Qˆt0) CILL CIUL
0 0.1 2.099 0.023 1.801 2.397
0.2 4.231 0.053 3.781 4.681
0.5 12.194 0.183 11.355 13.034
2 0.1 1.916 0.007 1.750 2.081
0.2 3.980 0.024 3.675 4.284
0.5 11.831 0.167 11.029 12.632
4 0.1 1.847 0.005 1.713 1.980
0.2 3.863 0.019 3.594 4.132
0.5 11.616 0.180 10.785 12.446
6 0.1 1.803 0.004 1.676 1.929
0.2 3.783 0.019 3.517 4.050
0.5 11.453 0.200 10.575 12.331
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Figure 3.2.1: Kaplan Meier Quantile vs. Weibull fitted Quantile plot (node positive patients)
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Figure 3.2.2: Kaplan Meier Quantile vs. Weibull fitted Quantile plot (node negative patients)
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3.3 TWO SAMPLE
In this section, we extend the one-sample results in Section 3.2 to two independent groups.
The results obtained in this section can be easily generalized to more than two groups. Other
than the number of groups, the setting is similar to one-sample case. In Section 3.3.1, basic
results are presented. Section 3.3.2 presents simulation results using the Weibull model, and
Section 3.3.3 applies the results to real data set.
3.3.1 Theory
We have a random sample of right censored data from each of the two populations. We
assume that the failure times in the two groups come from the same parametric family. Hence,
the random sample of failure times T1i, i = 1, . . . , n1 for group 1 comes from F (; θ
(1)). We also
have corresponding random sample of censoring times C1i ∼ G1(.), i = 1, . . . , n1. Similarly,
the failure times T2i, i = 1, . . . , n2 for group 2 comes from F (; θ
(2)) with a corresponding
random sample of censoring times from C2i ∼ G2(.), i = 1, . . . , n2. No assumption on the
functional dependency between θ(1) and θ(2) is made. We observe {(Xji, δji)}nji=1, j = 1, 2,
where
Xji = min{Tji, Cji} and δji = I(Tji ≤ Cji).
Using the observed data, we want to make inferences about the difference between the true
quantile residual residual life times at time t0,
Q
(1)
t0 (τ ; θ
(1))−Q(2)t0 (τ ; θ(2)) (3.3.11)
Likelihood based point and confidence interval estimators are derived below. The likelihood
for the observed data is:
L(θ | {(Xji, δji)}ni=1) =
2∏
j=1
nj∏
i=1
f(Xji; θ)
δjiS(Xji; θ)
1−δji
=
2∏
j=1
nj∏
i=1
h(Xji; θ)
δjiS(Xji; θ) ,
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where θ =
(
θ(1), θ(2)
)
is a vector of parameter vectors θ(1) and θ(2) for the distributions of T1i
and T2i, respectively. Thus, the log-likelihood is given by
`n(θ) =
n1∑
i=1
δ1i lnh(X1i; θ
(1)) + lnS(X1i; θ
(1)) +
n2∑
i=1
δ2i lnh(X2i; θ
(2)) + lnS(X2i; θ
(2)).
As a result of the assumed independence between the two groups, the joint log-likelihood
separates into the log-likelihood for each group. Thus, likelihood quantities and inference
follow directly from the one-sample case.
By the result in Section 3.2, and the invariance property of the MLEs, the MLE of
Q
(1)
t0
(
τ ; θ(1)
)−Q(2)t0 (τ ; θ(2)) is:
Q
(1)
t0
(
τ ; θˆ(1)
)
−Q(2)t0
(
τ ; θˆ(2)
)
(3.3.12)
where θˆ(1) and θˆ(2) are MLEs of θ(1) and θ(2), respectively.
The asymptotic distribution of Q
(1)
t0
(
τ ; θˆ(1)
)
− Q(2)t0
(
τ ; θˆ(2)
)
also follows by the delta
method. By the result in Section 3.2, Qˆ
(j)
t0 is consistent for Q
(j)
t0 , j = 1, 2, and asymptotically
normally distributed. Now, applying the delta method on the function g(Qˆ
(1)
t0 , Qˆ
(2)
t0 ) =
Qˆ
(1)
t0 − Qˆ(2)t0 , we get
Qˆ
(1)
t0 − Qˆ(2)t0 ∼ AN
(
Q
(1)
t0 −Q(2)t0 , Avar
(
Qˆ
(1)
t0
)
+ Avar
(
Qˆ
(2)
t0
))
(3.3.13)
where Avar(Qˆ
(j)
t0 ), j = 1, 2, is as in Equation 3.2.16; and its consistent estimator,
̂
Avar(Qˆ
(j)
t0 ),
is as in Equation 3.2.17, j = 1, 2.
Using the point estimate Qˆ
(1)
t0 − Qˆ(2)t0 and the estimator of its asymptotic variance, Wald-
type approximate tests and CIs can be constructed. An approximate two-sided 100(1− α)%
Wald confidence interval(CI) for Q
(1)
t0 −Q(2)t0 is:(
Qˆ
(1)
t0 − Qˆ(2)t0 ± z1−α/2
√
̂
Avar(Qˆ
(1)
t0 ) +
̂
Avar(Qˆ
(2)
t0 )
)
. (3.3.14)
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3.3.2 Simulation Study
We ran simulation studies to investigate the performance of the proposed method. The
simulation were conducted as in the one-sample case except for the following differences:
two samples were independently generated from the same population at each simulation
run; sample sizes of n = 100 and n = 200 per sample were used. Simulation results for the
two-sample setting are presented in Tables 3.3.1-3.3.2.
In each of the tables, asymptotic variance, Monte Carlo variance, empirical bias, and em-
pirical MSE for the estimated difference in quantile residual lifetime
(
∆Qˆt0 = Qˆ1,t0 − Qˆ2,t0
)
,
and 95% empirical coverage (CP) for the true difference in quantile residual life time are
shown.
The simulation results indicate that the method works well under all the simulation
scenarios considered. The asymptotic variance and the Monte Carlo variance are similar to
each other indicating that the model-based asymptotic variance formula performs well. The
quantile residual lifetime estimator is unbiased and the empirical coverage probability is close
to the nominal value.
Table 3.3.1: Two-sample simulation result, Weibull(α1 = α2 = 2, λ1 = λ2 = 0.5)
n t0 τ
̂Avar(∆Qˆt0)
̂var(∆Qˆt0) B̂ias M̂SE CP
200 0 0.25 0.004 0.004 -0.001 0.004 0.948
0.50 0.005 0.005 -0.002 0.005 0.953
1 0.25 0.001 0.001 -0.001 0.001 0.955
0.50 0.002 0.002 -0.002 0.002 0.950
100 0 0.25 0.008 0.008 -0.000 0.008 0.944
0.50 0.010 0.010 0.000 0.010 0.947
1 0.25 0.001 0.001 0.000 0.001 0.955
0.50 0.005 0.005 0.001 0.005 0.954
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Table 3.3.2: Two-sample simulation result, Weibull(α1 = α2 = 2, λ1 = λ2 = 0.25)
n t0 τ
̂Avar(∆Qˆt0)
̂var(∆Qˆt0) B̂ias M̂SE CP
200 0 0.25 0.008 0.008 -0.003 0.008 0.951
0.50 0.010 0.010 -0.003 0.010 0.955
1 0.25 0.002 0.002 -0.001 0.002 0.956
0.50 0.006 0.005 -0.002 0.005 0.954
100 0 0.25 0.016 0.016 0.001 0.016 0.948
0.50 0.020 0.020 0.002 0.020 0.950
1 0.25 0.004 0.004 0.001 0.004 0.953
0.50 0.011 0.011 0.001 0.011 0.946
3.3.3 Data Analysis
The analyses started in Section 4.2.5 is carried on here, where we apply the proposed method
for the two-sample setting on the B04-study data using nodal status as a grouping variable.
The difference in the quantile residual life time between the two nodal groups are estimated
at four time points t0 = 0, 2, 4, 6 and three quantile levels τ = 0.1, 0.2, 0.5. The results
are shown in Table 3.3.3. It is clearly seen that the nodal positive group has a shorter
remaining life time than the nodal negative group. This is consistent with the one-sample
result presented in Table 3.2.3.
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Table 3.3.3: Quantile residual life time difference between node-negative and node-positive
patients
t0 τ ∆Qˆt0
̂Avar(∆Qˆt0) CILL CIUL
0 0.1 1.107 0.035 0.739 1.474
0.2 1.997 0.088 1.416 2.579
0.5 4.590 0.354 3.425 5.755
2 0.1 0.764 0.011 0.563 0.966
0.2 1.502 0.039 1.116 1.889
0.5 3.811 0.320 2.702 4.921
4 0.1 0.644 0.008 0.470 0.817
0.2 1.290 0.034 0.930 1.649
0.5 3.387 0.360 2.212 4.563
6 0.1 0.566 0.008 0.394 0.739
0.2 1.146 0.036 0.775 1.517
0.5 3.071 0.415 1.809 4.334
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3.4 REGRESSION - ACCELERATED FAILURE TIME MODEL
So far, one sample and two sample settings in which the data in each sample are assumed to be
a random sample from an underlying distribution (homogeneous population) were considered.
The one-sample and two-sample procedures are valid for homogeneous populations.
In many applications, such as clinical trials and observational studies, there is hetero-
geneity among the study subjects that affects or is associated with failure time (Klein and
Moeschberger, 2003; Prentice et al., 1978). Thus, it is important to develop a procedure that
accommodates variability in the characteristics of individuals in a population. In this section,
the one-sample and the independent two-sample quantile residual life procedures developed
in previous sections are generalized to the regression case. There are two standard regression
approaches for modeling the effect of covariates on survival times: the proportional hazard
(PH) and the accelerated failure time (AFT) models.
Under the PH assumption, the effect of covariates is to scale up (down) the baseline
hazard function. Under the AFT approach, the effect of covariates is to scale up (down) the
baseline time-scale. This makes the AFT model a natural model for quantile inference. The
accelerated failure time approach provides an alternative approach to the PH approach (Wei,
1992); includes some PH models; may be more appropriate in some circumstances (Patel
et al., 2006; Kay and Kinnersley, 2002). We will use the AFT model to incorporate covariate
information.
3.4.1 Theory
Suppose on the log scale the failure time T can be written as a linear model
lnT = ZTβ + σε (3.4.11)
where ε ∼ fε(e). This log-linear model contains two types of parameters: β, the regression
coefficient and b, baseline parameter. The baseline parameter contains all parameters in the
baseline distribution, i.e., the distribution of T when Z = 0. In the above model, σ is part of
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the baseline parameter b. From equation 3.4.11, the survival function of T , S(x;Z) is given
by ∫ ∞
x
fε
(
lnT − ZTβ
σ
)
1
Tσ
dT.
Making the change of variable ε = lnT−Z
T β
σ
, we obtain
S(x;Z) =
∫ ∞
ln x−ZT β
σ
fε(ε) dε
= Sε
(
σ−1 lnx exp(−ZTβ);Z) .
Denoting the survival function of T for the population with baseline covariate Z = 0 by S0(x),
the above equation implies the following relationship between the baseline survival function
S0(x) and the survival function given a covariate Z, S(x;Z),
S(x;Z) = S0(x exp[−ZTβ]). (3.4.12)
This is an accelerated failure time (AFT) representation of the log-linear model in equation
3.4.11. The AFT model in 3.4.12 is equivalent to the following characterizations
h(x;Z) = h0(x exp[−βTZ]) exp(−βTZ) (3.4.13)
H(x;Z) = H0(x exp[−βTZ]). (3.4.14)
Using Equation 3.4.12 or Equation 3.4.14, the quantile residual life time for a population
with covariate vector Z is related to that of the baseline population as follows:
Qt0(τ ;Z, θ) = Qt0(τ ;Z = 0, θ) exp(β
TZ).
Thus, the effect of covariates on the quantiles is proportional. Likelihood-based inference of
Qt0(τ ;Z, θ) using observed failure times from a heterogeneous population is considered next.
The observed data from a heterogeneous population are similar to the homogeneous
population. In this case, the observed time Xi and censoring indicator δi for the i
th subject
are defined given the subject’s covariate vector Zi = (Z1i, Z2i, · · · , Zpi). The failure time Ti
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given Zi is assumed to be independent of Ci. Under this assumption, the likelihood of the
random sample {(Xi, δi,Zi)}ni=1 is given by,
L(θ | {(Xi, δi,Zi)}ni=1) =
n∏
i=1
f(Xi; θ,Zi)
δiS(Xi; θ,Zi)
1−δi ,
where θ = (b, β) is a vector of regression parameter vectors. b is a parametric vector for the
baseline distribution and β is a vector regression parameter. Using the AFT assumption, the
likelihood can be written as
L(θ | {(Xi, δi,Zi)}ni=1) =
n∏
i=1
[
h0(Xi exp(−βTZi)) exp(−βTZi)
]δi
S0(Xi exp(−βTZi))
=
n∏
i=1
[
h0(Xi exp(−βTZi)) exp(−βTZi)
]δi
exp
[−H0(Xi exp(−βTZi))] .
Thus, the log-likelihood takes the following form,
`n(θ) =
n∑
i=1
δi ln
[
h0(Xi exp(−βTZi))
]− n∑
i=1
δiβ
TZi −
n∑
i=1
H0(Xi exp(−βTZi)).
The score vector contains
∂`n
∂b
=
n∑
i=1
δi
∂`n
∂b
ln
[
h0(Xi exp(−βTZi))
]− n∑
i=1
∂`n
∂b
H0(Xi exp(−βTZi)), (3.4.15)
the score sub-vector corresponding to the baseline parameter vector b and
∂`n
∂β
=
n∑
i=1
δiZi −
n∑
i=1
[
δi
h′0(Xi exp(−βTZi))
h0(Xi exp(−βTZi)) −H
′
0(Xi exp(−βTZi))
]
Xi exp(−βTZi)Zi,
(3.4.16)
the score sub-vector corresponding to the regression coefficient vector β. The MLE of
θ = (b, β), θˆ = (bˆ, βˆ) is found by solving
∂`n
∂b
= 0, and
∂`n
∂β
= 0
for (b, β). The sample information matrix is given by
I(θ) = − ∂
2`n
∂θ∂θT
, where θ = (b, β). (3.4.17)
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A consistent estimator of Qt0(τ ;Z, θ) is Qˆt0 = Qt0(τ ;Z, θˆ) with its asymptotic variance
formula given by {
∇Qˆt0(τ ;Z)
}T
I−1(θ)
{
∇Qˆt0(τ ;Z)
}
, (3.4.18)
where ∇Qˆt0(τ ;Z) is:
∇Qˆt0(τ ;Z) =
∇bQˆt0(τ ;Z)
∇βQˆt0(τ ;Z)
 =
exp(βTZ)∇bQˆt0(τ ;Z = 0)
Qt0(τ ;Z = 0) exp(β
TZ)Z
 .
3.4.2 Application to the Weibull Model
The likelihood of right-censored data {(Xi, δi,Zi)}ni=1 based on baseline Weibull failure times
under random censorship is of the form:
L(α, λ, β) =
n∏
i=1
[αλ{Xi exp(βTZi)}α−1 exp(βTZi)]δi exp[−λ{Xi exp(βTZi)}α],
where the log-likelihood is given by
`n(α, λ, β) = (lnα + lnλ)
n∑
i=1
δi + (α− 1)
n∑
i=1
δi lnXi + α
n∑
i=1
δiβ
TZi − λ
n∑
i=1
{Xi exp(βTZi)}α.
Its score function is given by
∂`n
∂α
= α−1
n∑
i=1
δi +
n∑
i=1
δi(lnXi + β
TZi)− λ
n∑
i=1
{Xi exp(βTZi)}α(lnXi + βTZi)
∂`n
∂λ
= λ−1
n∑
i=1
δi −
n∑
i=1
{Xi exp(βTZi)}α ln(Xi exp(βTZi))
∂`n
∂βk
=
[
α
n∑
i=1
δi − λ
n∑
i=1
α{Xi exp(βTZi)}α
]
Zik where k = 1, 2, . . . , p.
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The information matrix is
∂2`n
∂2α
= −α−2
n∑
i=1
δi − λ
n∑
i=1
{Xi exp(βTZi)}α(lnXi + βTZi)2
∂2`n
∂βk∂α
=
[ n∑
i=1
δi − λ
n∑
i=1
{Xi exp(βTZi)}α − λα
n∑
i=1
{Xi exp(βTZi)}α(lnXi + βTZi)
]
Zik
∂2`n
∂λ∂βk
=
n∑
i=1
{Xi exp(βTZi)}αZik
∂2`n
∂2λ
= −λ−2
n∑
i=1
δi
∂2`n
∂λ∂βk
=
n∑
i=1
{Xi exp(βTZi)}αZik
∂2`n
∂βk∂βl
=
[
−λ
n∑
i=1
α2{Xi exp(βTZi)}α
]
ZikZil where k, l = 1, 2, . . . , p.
The asymptotic variance formula is given by{
∇Qˆt0(τ ;Z)
}T
I−1(θ)
{
∇Qˆt0(τ ;Z)
}
(3.4.21)
where ∇Qˆt0(τ ;Z) is:
∇Qˆt0(τ ;Z) =
 exp(−βˆTZ)∇bˆQˆt0(τ ;Z = 0)
−Qˆt0(τ ;Z = 0) exp(−βˆTZ)Z

where
∇bˆQˆt0(τ ;Z = 0) =
αˆ−2(tαˆ0 − λˆ−1 ln(1− τ))1/αˆ
(
αˆtαˆ0 ln(t0)
(tαˆ0−λˆ ln(1−τ))
− ln(tαˆ0 − λˆ ln(1− τ))
)
αˆ−1λˆ−2(tαˆ0 − λˆ−1 ln(1− τ))−1+1/α ln(1− τ)

and
Qˆt0(τ ;Z = 0) =
([
tαˆ0 − λˆ−1 ln(1− τ)
]1/αˆ
− t0
)
.
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3.4.3 Simulation Study
We conducted simulation studies to investigate the performance of the proposed method.
Weibull(α = 2, λ = 0.5) was used as the baseline distribution. A bivariate vector (Z1, Z2)
was generated by simulating Z1 from Bernoulli(0.5) and Z2 from N(0, 1). The regression
coefficient for Z1 was set at β1 = 0.5 and for Z2 was set at β2 = 1. A censoring proportion of
0.3 was used. A sample size of 200 and Monte Carlo sample size of 5000 were used.
Inference for the true residual quantile life at the two values of the dichotomous variable
(Z1 = 0, 1) and at two values of the continuous covariates (Z2 = 0, 1) were investigated. The
simulation results for these settings are given in Tables 3.4.1-3.4.4. The results suggest that
the proposed procedure works well. The coverage probability is close to the nominal level,
the estimates are unbiased, and the asymptotic and Monte Carlo variances are close to each
other.
Table 3.4.1: Regression simulation result (Z1 = 0, Z2 = 0)
t0 τ Qˆt0
̂Avar(Qt0) Qt0
̂var(Qˆt0) B̂ias M̂SE CP
0 0.25 0.764 0.003 0.759 0.003 0.006 0.003 0.945
0.50 1.179 0.005 1.177 0.005 0.002 0.005 0.944
1 0.25 0.254 0.001 0.255 0.001 -0.001 0.001 0.943
0.50 0.541 0.003 0.545 0.003 -0.003 0.003 0.942
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Table 3.4.2: Regression simulation result (Z1 = 1, Z2 = 0)
t0 τ Qˆt0
̂Avar(Qt0) Qt0
̂var(Qˆt0) B̂ias M̂SE CP
0 0.25 1.259 0.009 1.251 0.009 0.008 0.009 0.951
0.50 1.943 0.017 1.941 0.016 0.002 0.016 0.948
1 0.25 0.418 0.001 0.421 0.001 -0.002 0.001 0.938
0.50 0.891 0.006 0.898 0.006 -0.007 0.006 0.938
Table 3.4.3: Regression simulation result (Z1 = 0, Z2 = 1)
t0 τ Qˆt0
̂Avar(Qt0) Qt0
̂var(Qˆt0) B̂ias M̂SE CP
0 0.25 2.081 0.037 2.062 0.038 0.020 0.038 0.953
0.50 3.212 0.076 3.201 0.077 0.011 0.077 0.948
1 0.25 0.692 0.008 0.694 0.009 -0.001 0.009 0.939
0.50 1.474 0.035 1.481 0.036 -0.007 0.036 0.937
Table 3.4.4: Regression simulation result (Z1 = 1, Z2 = 1)
t0 τ Qˆt0
̂Avar(Qt0) Qt0
̂var(Qˆt0) B̂ias M̂SE CP
0 0.25 3.443 0.115 3.399 0.115 0.043 0.117 0.951
0.50 5.310 0.245 5.277 0.246 0.033 0.247 0.949
1 0.25 1.142 0.018 1.143 0.018 -0.001 0.018 0.939
0.50 2.432 0.081 2.441 0.081 -0.010 0.081 0.938
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3.4.4 Data Analysis
For the regression analysis, we fitted a Weibull regression model using the combined (node
negative and node positive patients) dataset. We used the covariates node status, age (in
years) and tumor size (in mm) as covariates. Based on the fitted model, estimates of the
quantile residual life for a node-negative patient at the median age (57 yr) and median tumor
size (30 mm) are presented in Table 3.4.5. The corresponding estimates for a node-positive
patient at the median age (55 yr) and median tumor size (32 mm) are given in Table 3.4.6.
The results are similar to the results presented in the one-sample setting. We also observe
the lack of appreciable dependency of the estimated quantile residual life times on the time
points, suggesting that the baseline shape parameter is close to 1 and exponential regression
might work for the data.
We checked the plausibility of the assumed Weibull model using the Quantile-Quantile
plot of the Kaplan Meier estimator and the fitted Weibull model (see Figure 3.4.1). The
assumed model appears to fit the data well.
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Table 3.4.5: Quantile residual life analysis for a node-negative patient at the median age
(57 yrs) and tumor size (30 mm)
t0 τ Qˆt0
̂Avar(Qˆt0) CILL CIUL
0 0.1 1.926 0.014 1.692 2.160
0.2 3.985 0.038 3.605 4.365
0.5 11.949 0.185 11.106 12.792
2 0.1 1.826 0.005 1.693 1.959
0.2 3.840 0.019 3.570 4.111
0.5 11.724 0.178 10.898 12.550
4 0.1 1.793 0.004 1.668 1.917
0.2 3.781 0.018 3.516 4.046
0.5 11.603 0.196 10.734 12.471
6 0.1 1.772 0.004 1.644 1.901
0.2 3.742 0.020 3.465 4.019
0.5 11.515 0.220 10.595 12.434
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Table 3.4.6: Quantile residual life analysis for a node-positive patient at median age (55 yrs)
and tumor size (32 mm)
t0 τ Qˆt0
̂Avar(Qˆt0) CILL CIUL
0 0.1 1.361 0.010 1.168 1.553
0.2 2.815 0.028 2.486 3.144
0.5 8.441 0.158 7.662 9.220
2 0.1 1.290 0.004 1.165 1.415
0.2 2.713 0.017 2.459 2.967
0.5 8.282 0.145 7.534 9.029
4 0.1 1.266 0.004 1.150 1.383
0.2 2.671 0.015 2.427 2.915
0.5 8.196 0.150 7.438 8.954
6 0.1 1.252 0.003 1.136 1.367
0.2 2.643 0.016 2.398 2.889
0.5 8.134 0.158 7.356 8.912
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Figure 3.4.1: Kaplan Meier Quantile vs. Weibull fitted Quantile plot
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4.0 COMPETING RISKS
In Chapter 3, parametric inference for the residual quantile life function of a failure time was
considered. In some applications, it is important to make inference on the quantile residual
life function of a failure time from a particular cause of failure in the presence of at least one
other cause of failure. This is a competing risks problem.
In this chapter, parametric procedures developed previously are extended to the competing
risks scenario. Parametric inferences for one sample, two-sample, and regression cases are
developed. The performance of the methods is investigated using simulations. The methods
are applied to a real data set.
4.1 INTRODUCTION
In Section 3.1, survival quantities that are important to describe a failure time distribution
were presented. In this section, we will present corresponding survival quantities for the
competing risks situation. In some survival studies, we have failures due to several causes.
For instance, in survival study of cancer patients, where the primary event of interest is time
to death due to cancer, mortality from non-cancer causes occurs precluding (censoring) the
primary event from occurring. In such a scenario, we observe a failure time and failure type
(death due to cancer and death due non-cancer causes). This is an example of a competing
risks problem. Generally, competing risk data are of the type (T, δ), where T is a failure
time and δ is a failure type variable. In medical studies, T is subject to a random right
censoring. Under random censorship, the only survival quantities that are identifiable from
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the competing risks data are cause-specific hazards or functions of them Prentice et al. (1978).
This fact is the basis for the cause-specific hazard modeling framework, where the hazards
for each cause are modeled separately.
The survival quantities presented in Section 3.1 are generalized to competing risks below.
They are defined by cause type. Without loss of generality, we will assume that there are
two distinct types or causes of failure.
The kth cause-specific hazard function is defined as
hk(t) = lim
∆t→0
P [t ≤ T < t+ ∆t, δ = k|T ≥ t]
∆t
=
fk(t)
S(t)
k = 1, 2, (4.1.01)
where fk(t) is the density of (T, δ = k) and S(t) is the all cause survival function. The k
th
cause hazard function quantifies the rate at which subjects who are still at risk of failing
at time t from any cause are failing from the kth cause at time t. Because the two event
types are mutually exclusive, the cause-specific hazard functions add up to the overall hazard
function,
h(t) = h1(t) + h2(t). (4.1.02)
Upon integrating both sides of Equation 4.1.02, we get∫ t
0
h(u) du =
∫ t
0
h1(u) du+
∫ t
0
h2(u) du
H(t) = H1(t) +H2(t). (4.1.03)
That is, the cause-specific cumulative hazard functions add up to the overall cumulative hazard
function. Using the fact that S(t) = exp(−H(t)) and the decomposition in Equation 4.1.03,
the all cause survival function can be written as,
S(t) = exp(−H1(t)−H2(t)) = S1(t)S2(t), (4.1.04)
where we have denoted exp(−Hk(t)) by Sk(t) for k = 1, 2.
38
To define the kth cause τ -quantile residual life, we need the subdistribution function or
cumulative incidence function for the kth cause,
Fk(t) = P (T ≤ t, δ = k) =
∫ t
0
fk(u)du =
∫ t
0
S(u)hk(u)du
=
∫ t
0
exp(−H(u))hk(u)du, k = 1, 2 (4.1.05)
where we have used Equation 4.1.01 in the third equality. Equation 4.1.05 suggests that Fk(t)
is completely determined by the cause-specific hazard functions. Using Equation 4.1.05, we
can easily see that distribution function of T is related to the kth cause cumulative incidence
functions as F (t) = F1(t) + F2(t). Similarly, the density function of T is related to the
densities of the kth cause cumulative incidence function as f(t) = f1(t) + f2(t).
Given F and Fk, the τ -quantile residual life time for the k
th cause, Qk,t0(τ), is defined as
Qk,t0(τ) = F
−1
k,t0
(τ), τ ∈ (0, Fk(∞));
where Fk,t0(t) denotes the distribution function of (T − t0, δ = k)|T > t0. The kth cause
τ -quantile residual life at time t0, Qk,t0(τ), can be written in terms of the k
th cause τ -quantile
residual life at time t0 = 0, Qk(τ). Indeed,
Fk,t0(t) = P (T − t0 ≤ t, δ = k | T ≥ t0)
=
P (t0 < T ≤ t+ t0, δ = k)
P (T > t0)
.
This implies
Fk,t0(t) =
Fk(t+ t0)− Fk(t0)
1− F (t0) (4.1.06)
when T > t0. Thus,
Q1,t0(τ) = F
−1
1 (τ(1− F (t0)) + F1(t0))− t0 (4.1.07)
where 0 < τ < 1. Equation 4.1.07 is equivalent to:
Q1,t0(τ) = Q1(τ(1− F (t0)) + F1(t0))− t0. (4.1.08)
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For parametric inference on Q1,t0(τ), we will place a parametric assumption on Fk(t) via
parameterizing the cause-specific hazards hk(t)(k = 1, 2), which are estimable from competing
risks data and completely determine the competing risks process (Beyersmann et al., 2009).
Since there is little restriction on the hazard function, this approach allows us to flexibly
choose the forms of the cause-specific hazards. This approach also automatically gurantees the
improperness of Fk(t) (k = 1, 2) and their additivity to F (t) (see Shi et al. (2013)). Moreover,
when the cause-specific hazards do not share any parameter, the methods of Chapter 3 can
be directly used for constructing and estimating the likelihood quantities.
As in Chapter 3, we will assume that regularity conditions needed to make the asymptotics
work hold. In particular, we will assume that Q1,t0(τ) is differentiable with respect to θ.
4.2 ONE SAMPLE
In this section, parametric inference on the true residual quantile life time based on a random
sample of right-censored data from a homogeneous population under a competing-risks setting
is considered.
4.2.1 Theory
Without loss of generality, we will assume that there are two types of failure, k = 1, 2.
Suppose we have a random sample of potential failure times {Ti}ni=1 from a distribution
function F (·; θ) and a corresponding sample of potential censoring times {Ci}ni=1 from a
distribution function G(·). If the observed time is a failure time, the failure type is one of
the two types. The observed data are a random sample {(Xi, δki)}ni=1 where Xi = min(Ti, Ci)
and δki are the observed time and failure type indicator respectively for the i
th observation.
δki = 1, if the failure type is k, and Xi = Ti. Otherwise, δik = 0. If δi1 = δi2 = 0, then the i
th
observation is censored. Based on the observed data, inference on Q1,t0 , the true quantile
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residual life time for failure times of failure type or cause 1 at time t0,
Q1,t0(τ ; θ) = F
−1
1 (τ(1− F (t0; θ)) + F1(t0; θ))− t0 (4.2.11)
is considered. Likelihood based point and confidence interval estimators are developed below.
The likelihood function for the competing risks data is
L(θ | {(Xi, δki)}ni=1) =
n∏
i=1
f1(Xi; θ)
δ1if2(Xi; θ)
δ2iS(Xi; θ)
1−(δ1i+δ2i)
where θ = (θ1, θ2) with θk = (θk1, θk2, . . . , θkpk) being the vector of parameters corresponding
to the kth cause.
The likelihood can be written in terms of the cause-specific hazards as
L(θ | {(Xi, δki)}ni=1) =
n∏
i=1
h1(Xi; θ1)
δ1ih2(Xi; θ2)
δ2iS(Xi; θ) (4.2.12)
=
n∏
i=1
h1(Xi; θ1)
δ1iS1(Xi; θ1)
n∏
i=1
h2(Xi; θ2)
δ2iS2(Xi; θ2), (4.2.13)
where we have used the identity S(Xi; θ) = S1(Xi; θ1)S2(Xi; θ2) to go from 4.2.12 to 4.2.13.
Due to the factorization of the likelihood into the likelihood contribution for each cause, the
likelihood quantities for each cause can be estimated separately. Equation 4.2.13 implies
that likelihood quantities for the kth cause can be estimated in the usual way by censoring
failure times from the other causes at their observed times. Thus, likelihood quantities
(log-likelihood, score vectors, MLEs, and information matrix) for each cause are exactly as in
Section 3.2.
By the consistency of θˆ, the MLE of θ = (θ1, θ2), and the differentiability of Q1,t0(τ ; θ), a
consistent estimator of the quantile residual life time for the failure time of failure type 1 is,
Qˆ1,t0(τ ; θ) = Q1,t0(τ ; θˆ) = F
−1
1 (τ(1− F (t0; θˆ)) + F1(t0; θˆ))− t0. (4.2.14)
Using the same argument as in Section 3.2, the asymptotic distribution of Qˆ1,t0(τ ; θ) follows
Qˆ1,t0 ∼ AN
(
Q1,t0 , Avar(Qˆ1,t0)
)
, (4.2.15)
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where
Avar(Qˆ1,t0) =
1
n
{
∇θˆQ1,t0(τ ; θˆ)|θˆ=θ
}T
I−1(θ)
{
∇θˆQt0(τ ; θˆ)|θˆ=θ
}
. (4.2.16)
I−1(θ) in Equation 4.2.16 is the inverse of the expected information matrix and is consistently
estimable by nI−1(θˆ). I−1(θˆ) is the inverse of the sample Fisher information matrix evaluated
at θˆ, the MLE of θ. The sample Fisher information matrix is given by
I(θ) = − ∂
2
∂θ∂θT
`n(θ).
For inference (testing and confidence intervals) on the quantile residual life time of the failure
type 1, the unknown quantities in Equation 4.2.16 are estimated by their consistent estimators.
A consistent estimator of the asymptotic variance (Equation‘4.2.16) is given by
̂Avar(Qˆ1,t0) =
{
∇θˆQ1,t0(τ ; θˆ)|θˆ=θˆ
}T
I−1(θˆ)
{
∇θˆQ1,t0(τ ; θˆ)|θˆ=θˆ
}
. (4.2.17)
Using the point estimate Qˆ1,t0 and the estimator of its asymptotic variance, Wald-type
approximate tests and CIs for Q1,t0 can be constructed. An approximate two-sided 100(1−α)%
Wald confidence interval(CI) for Q1,t0(τ ; θ) is:(
Qˆt1,0(τ ; θ)± z1−α/2
√
̂Avar(Qˆ1,t0)
)
. (4.2.18)
4.2.2 Computational Issues
In Section 4.2.1, the applicability of the formulas for the cause-specific quantile residual
life (Equation 4.2.14) and asymptotic variance of the cause-specific quantile residual life
(Equation 4.2.16) relies on their computability. Generally, the cause-specific quantile residual
life does not have a closed form. This means the gradient of the cause-specific quantile residual
life in the asymptotic variance formula cannot be calculated analytically. This lack of closed-
form representation of the quantile residual life also complicates the simulation of competing
risks data. These computational issues do not normally arise in the non-competing risks
settings. We have not seen any reference or solutions to these problems in the competing-risks
literature. We will propose a solution to this problem in this section.
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4.2.2.1 Estimation of the Quantile Residual Life The kth-cause quantile residual
life time Qk,t0(τ) satisfies the following equation,
Fk,t0(Qk,t0(τ)) =
Fk(Qk,t0(τ) + t0)− Fk(t0)
S(t0)
= τ.
This implies
Fk(Qk,t0(τ) + t0)− Fk(t0)− S(t0)τ = 0,
which can be written as ∫ Qk,t0 (τ)+t0
t0
fk(u) du− S(t0)τ = 0. (4.2.21)
The quantile residual life time can be determined by solving Equation 4.2.21 for Qk,t0(τ). In
cases where the integral has has a closed form representation, the quantile residual life time
can be solved analytically. Generally, the quantile residual life time has to be determined
numerically. We will suggest an algorithm for obtaining the quantile residual life time
numerically. To do so, we will write the left-hand-side of Equation 4.2.21 as a function in q?,
R(q?) =
∫ q?
t0
fk(u) du− S(t0)τ, (4.2.22)
where q? = Qk,t0(τ) + t0. The quantile residual life time is the root of R(q
?) minus t0. The
root of R(q?) can be found using the Newton-Raphson algorithm. Indeed, given an initial
value q?0, the first iterate q
?
1 is given by
q?1 = q
?
0 −
R(q?0)
fk(q?0)
.
Generally, given the nth iterate q?n, the (n+ 1)
th iterate q?n+1 is given by
q?n+1 = q
?
n −
R(q?n)
fk(q?n)
.
This iteration continues until some convergence criterion, say, |q?n+1−q?n| ≤ c, for c a tolerance
limit, is met. Since R(q?) is not available analytically, it should also be estimated numerically
at each iteration. Suppose the final iterate is denoted by q?n? , the quantile residual life is
given by Qk,t0(τ) = q
?
n? − t0.
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All the quantile functions and density functions above are functions of a distributional
parameter vector, θ. When θ is a known (for example, in a simulation study), the quantile
residual life determined by the above scheme is the true quantile residual life for the population
with that parameter value. When the θ is replaced by its estimator θˆ, the quantile residual
life determined by the above scheme is an estimate of the true quantile residual life.
4.2.2.2 Estimation of the gradient of the Quantile Residual Life The asymptotics
of the quantile residual life requires the determination of the gradient of the estimated quantile
residual life. The determination of the gradient formula is given below.
Consider finding the gradient of both sides of Equation 4.2.21, i.e.,
∇θˆ
∫ Qk,t0 (τ)+t0
t0
fk(u) du− τ∇θˆS(t0) = 0.
Applying Leibniz’s rule for differentiation under the integral sign, we obtain∫ Qk,t0 (τ)+t0
t0
∇θˆfk(u; .) du+ fk(Qj,t0(τ) + t0)∇θˆQk,t0(τ)− τ∇θˆS(t0) = 0.
Interchange integration and differentiation to get
∇θˆ
∫ Qk,t0 (τ)+t0
t0
fk(u; .) du+ fk(Qk,t0(τ) + t0)∇θˆQk,t0(τ)− τ∇θˆS(t0) = 0,
which can be written as
∇θˆ
{
Fk(Qk,t0(τ) + t0; .)− Fk(t0; .)
}
+ fk(Qk,t0(τ) + t0)∇θˆQk,t0(τ ; .)− τ∇θˆS(t0; .) = 0.
Solving for the gradient of the quantile residual life time, we get
∇θˆQk,t0(τ) = fk(Qk,t0(τ) + t0)−1 {∇θˆFk(t0; .)−∇θˆFk(Qk,t0(τ) + t0; .)− τ∇θˆF (t0; .)} .
(4.2.23)
In Equation 4.2.23, the gradient with respect to θˆ of the kth cause cumulative incidence function
is obtained by first differentiating the kth cause sub-density and numerically integrating it.
This interchange of integration and differentiation allows us to numerically obtain the gradient
of Fk(t; .) (and, hence, that of Qk,t0(τ)) when neither is available in closed form. Thus, the
asymptotic variance of the cause-specific quantile residual life time can be expressed in terms
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of the gradient of the cumulative incidence functions. This formula is particularly useful
when the cause-specific quantile residual life time does not have an explicit representation
(i.e., when it is a result of a numerical iteration).
In the case of non-competing risks setting, Equation 4.2.23 is reduced to
∇θˆQt0(τ) = f(Qt0(τ) + t0)−1 {(1− τ)∇θˆF (t0; .)−∇θˆF (Qt0(τ) + t0; .)} .
4.2.2.3 Simulating Competing Risks Data The lack of a closed-form expression of the
cumulative incidence function (hence, the cause-specific quantiles) complicates the simulation
of competing risks data. We will show this difficulty by reviewing competing risks simulation
procedures in use in the literature. Competing risks data are mostly simulated using the
latent failure time approach (Beyersmann et al., 2009). This approach has limitations because,
among other things, it requires the specification of dependency structure among the cause-
specific latent failure times and has physical and statistical identifiability problems (Prentice
et al., 1978). We won’t consider this approach in the review below. Competing risk data that
don’t use the latent failure time approach are simulated in either of the following two methods.
Method 1:
This method uses a mixture representation of the distribution of the all cause failure time T
in terms of the sub-distributions of the competing causes. In the case where there are only
two competing causes (k = 1, 2) of failure, we have
P (T ≤ t) = P (T ≤ t, δ = 1) + P (T ≤ t, δ = 2)
= P (δ = 1)P (T ≤ t|δ = 1) + P (δ = 2)P (T ≤ t|δ = 2) (4.2.24)
where
P (T ≤ t, δ = k) =
∫ t
0
S(u)hk(u)du,
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and
P (δ = k) =
∫ ∞
0
S(u)hk(u)du, (4.2.25)
with P (δ = 1) + P (δ = 2) = 1.
This implies
P (T ≤ t|δ = k) =
∫ t
0
P (δ = k)−1S(u)hk(u)du.
Thus, the density of T |δ = k is:
P (δ = k)−1S(t)hk(t). (4.2.26)
Method 1 uses the mixture representation in Equation (4.2.24) to first generate the failure
type from a Bernoulli(1, P (δ = k)) and then generate a failure time from T |δ = k, where
its density is given in Equation (4.2.26). This method has been used, for example, by Jeong
and Fine (2013), Jeong and Fine (2009) and Ng and McLachlan (2003) where they assume
that T |δ = k follow Weibull, Gompertz, and exponential distributions, respectively. This
simplifying assumption makes simulating from T |δ = k straightforward.
Under the cause-specific hazard modelling approach used in this dissertation, Equation
(4.2.26) does not have simple distributional form even in simple settings where we assume
that each cause-specific hazard can be independently modeled by Weibull hazard functions.
The application of Method 1 to the cause-specific hazard modelling set-up requires the
determination of P (δ = k). This marginal probability of failure type 1 is not generally
available analytically. Thus, it has to be usually estimated numerically. Moreover, once
P (δ = k) is found, we should be able to simulate from P (δ = k)−1S(u)hk, which maybe not
be amenable to standard simulation procedures such as the inverse transform method. We
propose below the use of the Accept-Reject algorithm to simulate from T |δ = k.
To utilize the Accept-Reject algorithm, we need a density that is easy to simulate from
and that dominates the target density. To come up with a suitable dominating density, we
write Equation (4.2.26) as
P (δ = k)−1 exp(−H1(t)−H2(t))hk(t) ≤ P (δ = k)−1 exp(−Hk(t))hk(t), (4.2.27)
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where the upper bound follows from the fact that Sk(t) ≤ 1 (k = 1, 2). The expression
exp(−Hk(t))hk(t) in the upper bound is the so-called instrumental (or dominating) density
and P (δ = k)−1 is the expected number of attempts for each acceptance (see Casella and
Robert (2004)).
To simulate T from the target density P (δ = k)−1 exp(−H1(t) −H2(t))hk(t) using the
Accept-Reject algorithm, we generate X from the dominating density exp(−Hk(x))hk(x),
and conditional on X = x we simulate a uniform random variate U |x from Unif(0, P (δ =
k)−1 exp(−Hk(x))hk(x)). If 0 < u < P (δ = k)−1 exp(−H1(x)−H2(x))hk(x), we take T = x
(i.e, x is accepted). Otherwise, this procedure is started over (i.e., x is rejected).
We illustrate this method using the Weibull model. When the cause-specific shape
parameters in the Weibull-model, α1 and α2, are allowed to vary independently, there is no
closed-form expression for the kth cause cumulative incidence function nor for the density
of T |δ = k. In this case, to simulate competing risks data from T |δ = k, we first estimate
P (δ = k)−1 numerically. Then, we apply the Accept-Reject algorithm to simulate from the
density of T |δ = k. For the Weibull model, Equation 4.2.27 is given by,
P (δ = k)−1 exp(−λ1tα1 +−λ2tα2)λkαktαk−1 ≤ P (δ = k)−1 exp(−λktαk)(λkαktαk−1),
where exp(−λktαk)(λkαktαk−1) is the instrumental (or dominating) density and P (δ = k)−1
is the expected number of attempts for each acceptance. The dominating density is that of a
Weibull random variable.
Method 2:
This method, discussed in Beyersmann et al. (2009), suggests simulating first from the
distribution function for the all cause failure time T , and conditional on the observed fail-
ure time T = t assigning a failure type according to a random draw of causes from a
Bernoulli
(
1, hk(t)
h1(t)+h2(t)
)
with k = 1, 2. When it is easy to simulate from the distribution
function of the all cause failure time T , this method can be conveniently used to generate com-
peting risks data. Simulating competing risks data using this method when the cause-specific
hazards are parameterized independently is not obvious.
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4.2.3 Application to the Weibull Model
4.2.3.1 Independent shape and scale parameters The hazard function for the
Weibull distribution is: αλtα−1. Thus, the kth cause-specific hazard function is
hk(t;αk, λk) = αkλkt
αk−1.
Thus, the all cause survival function is S(t;α1, λ1, α2, λ2) = exp(−λ1tα1 − λ2tα2). Hence, the
kth cause cumulative incidence function is given by,
Fk(t;α1, λ1, α2, λ2) =
∫ t
0
exp(−λ1uα1 − λ2uα2)αkλkuαk−1du , k = 1, 2. (4.2.31)
The kth cumulative incidence function (Equation 4.2.31) does not have a closed form except in
the case of common shape parameter, i.e., α1 = α2 = α. Thus, in the case of independent shape
parameters, the quantile residual life time and its gradient should be evaluated numerically
using the procedure discussed in Section 4.2.2.1 and Section 4.2.2.2, respectively.
Using the result in Section 4.1, the likelihood based on a right-censored competing risks
data is:
L(α1, λ1, α2, λ2 | {(Xi, δki)}ni=1)
∝
n∏
i=1
(α1λ1X
α1−1
i )
δ1i exp(−λ1Xα1i − λ2Xα2i )
n∏
i=1
(α2λ2X
α2−1
i )
δ2i exp(−λ1Xα1i − λ2Xα2i ).
As was pointed out in Section 4.1, the joint likelihood factorizes into likelihoods for one-
sample Weibull likelihood of Section 3.2. Thus, all likelihood quantities (log-likelihood, score
vectors, MLEs, and information matrix) for each cause are the same as in Section 3.2.2.
The kth cause-specific quantile residual life, Qk,t0 , has to be determined numerically using
Equation 4.2.22 where fk and S(t0) in the equation are
fk(t;α1, λ1, α2, λ2) = exp(−λ1uα1 − λ2uα2)αkλkuαk−1du , k = 1, 2, (4.2.32)
and
S(t0;α1, λ1, α2, λ2) = exp(−λ1tα10 − λ2tα20 ). (4.2.33)
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The gradient of the cause-specific quantile residual life is found using Equation 4.2.23 where
the elements of the gradient of F1(t; .) are
∂F1(t; .)
∂λ1
=
∫ t
0
α1u
α1−1 [1− λ1uα1 ] exp(α1 exp(−λ1uα1 − λ2uα2) du
∂F1(t; .)
∂λ2
=
∫ t
0
−λ1α1uα1+α2−1 exp(−λ1uα1 − λ2uα2) du
∂F1(t; .)
∂α1
=
∫ t
0
λ1u
α1−1 (1 + α1 [1− λ1uα1 ] [ln (u)]) exp(−λ1uα1 − λ2uα2) du
∂F1(t; .)
∂α2
=
∫ t
0
−λ1λ2 [ln(u)]α1uα1+α2 exp (−λ1uα1 − λ2uα2) du,
and the elements of the gradient of F (t, .) are,
∂F (t; .)
∂λk
= tαk exp(−λ1tα1 − λ2tα2)
∂F (t; .)
∂αk
= λk [ln(t)] t
α1 exp(−λ1tα1 − λ2tα2), k = 1, 2.
4.2.3.2 Common shape parameter (α1 = α2) Under the assumption that α1 = α2 =
α, the sub-distribution function (cumulative incidence function) for the failure time of type k
is given by
Fk(t;α, λ1, λ2) =
λk
λ1 + λ2
(1− exp(−[λ1 + λ2]tα)).
Thus, in this case, the quantile residual life and its gradient can be found analytically.
Competing risks data can be simulated easily from this model using either Method 1 or
Method 2.
The likelihood is
L(α, λ1, λ2|{(Xi, δki)}ni=1, k = 1, 2) =
n∏
i=1
(αλ1X
α−1
i )
δ1i(αλ2X
α−1
i )
δ2i exp[−(λ1 + λ2)Xαi ],
whereas the log-likelihood is
`n(α, λ1, λ2) = lnλ1
n∑
i=1
δ1i+lnλ2
n∑
i=1
δ2i+lnα
n∑
i=1
(δ1i+δ2i)+(α−1)
n∑
i=1
(δ1i+δ2i) lnXi−(λ1+λ2)
n∑
i=1
Xαi .
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The score vector contains the following elements:
∂
∂α
`n(α, λ1, λ2) =
∑n
i=1 δ1i + δ2i
α
+
n∑
i
(δ1i + δ2i) ln(Xi)− (λ1 + λ2)
n∑
i=1
Xαi ln(Xi)
∂
∂λk
`n(α, λ1, λ2) =
∑n
i=1 δji
λk
−
n∑
i=1
Xαi , k = 1, 2.
The maximum likelihood estimator (MLE) of λk (k = 1, 2) is
λˆk =
∑n
i=1 δki∑n
i=1X
αˆ
i
,
whereas the MLE of α is a solution of the following non-linear equation:
n∑
i=1
(δ1i + δ2i) + α
n∑
i=1
(δ1i + δ2i) ln(Xi)− α
( n∑
i=1
δ1i + δ2i
)( n∑
i
Xαi
)−1 n∑
i=1
Xαi ln(Xi) = 0.
The elements of the the sample information matrix are:
I11(α, λ1, λ2) =
[
α−2
n∑
i=1
(δ1i + δ2i) + (λ1 + λ2)
n∑
i=1
Xαi (ln(Xi))
2
]
I22(α, λ1, λ2) =
[
λ−21
n∑
i=1
δ1i
]
I21(α, λ1, λ2) = I12(α, λ1, λ2) =
n∑
i=1
Xαi ln(Xi)
I33(α, λ1, λ2) =
[
λ−22
n∑
i=1
δ2i
]
I31(α, λ1, λ2) = I13(α, λ1, λ2) =
n∑
i=1
Xαi ln(Xi)
I32(α, λ1, λ2) = I23(α, λ1, λ2) = 0.
The quantile residual life time function for the sub-distribution of failure time of type 1 is:
Q1,t0(τ ;α, λ1, λ2) =
[
tα0 − [λ1 + λ2]−1 ln
(
1− τ(λ1 + λ2)
λ1
)]1/α
− t0,
which, upon letting λ1 = λ and λ2 = 0, is reduced to Qt0(τ ;α, λ1), the quantile resid-
ual life of the Weibull model. The maximum likelihood estimator of Q1,t0(τ ;α, λ1, λ2) is
Q1,t0(τ ; αˆ, λˆ1, λˆ2).
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The gradient vector of the MLE of the quantile residual life function contains the following
entries,
∂
∂αˆ
Q1,t0(τ ;α, λˆ1, λˆ2) = αˆ
−2
(
tαˆ0 − λ˜−1 ln[1− τ exp(−λ˜)]
)1/αˆ
 αˆtαˆ0 ln(t0){
tαˆ0 − λ˜ ln[1− τ exp(−λ˜)]
} − ln{tαˆ0 − λ˜ ln[1− τ exp(−λ˜)]}

∂
∂λˆ1
Q1,t0(τ ; λˆ1, λˆ2) = αˆ
−1λˆ2λˆ−2
{
tαˆ0 − λ˜−1 ln[1− τ exp(−λ˜)]
}−1+1/αˆ
ln[1− τ exp(−λ˜)]
∂
∂λˆ2
Q1,t0(τ ; λˆ1, λˆ2) = αˆ
−1λˆ1λˆ−2
{
tαˆ0 − λ˜−1 ln[1− τ exp(−λ˜)]
}−1+1/αˆ
ln[1− τ exp(−λ˜)],
where λ˜ = λˆ1 + λˆ2.
The estimator of asymptotic variance of the MLE of the quantile (residual) life function
is given by: {
∇Q1,t0(τ ; αˆ, λˆ1, λˆ2)
}T
I−1(αˆ, λˆ1, λˆ2)
{
∇Q1,t0(τ ; αˆ, λˆ1, λˆ2)
}
.
4.2.4 Simulation Study
Simulation Method 2 was used to generate the competing risks data. The all cause failure time
T was generated from the Weibull(2, λ = λ1 + λ2), where λk is the k
th cause scale parameter.
Given an observed time T = t from the all cause failure time distribution, the failure time
is a failure of type 1 with probability λ1
λ1+λ2
and of a failure type 2 with probability λ2
λ1+λ2
.
Two λ levels, λ = 0.5 with λ1 = 0.375 and λ2 = 0.125, and λ = 0.25 with λ1 = 0.1875 and
λ2 = 0.0625; two quantile levels τ = 0.25, 0.5 ; two time levels t0 = 0, 1; and two sample sizes
n = 100, 400 were used. The censoring proportion was set at 0.1, where the censoring times
were generated from uniform distribution. 5000 data sets were simulated at each simulation
setting.
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Simulation results are in shown in Tables 4.2.1-4.2.2. In each of the tables, the estimated
quantile residual life time for cause 1, its estimated asymptotic variance, its empirical variance,
empirical bias, empirical MSE and 95% coverage probability of the true quantile residual life
time for cause 1 are shown.
The results indicate that the procedure performs well under all simulation settings. The
asymptotic and Monte Carlo variances are similar to each other, and the cause 1 quantile
residual life time estimator is unbiased and has small MSE. The empirical coverage probability
is close to the nominal coverage probability (95%) .
Table 4.2.1: One-sample simulation result(α = 2, λ = 0.375 cause 1 and λ = 0.125 cause 2)
n t0 τ Qˆ1,t0
̂Avar(Qˆ1,t0)
̂var(Qˆ1,t0) B̂ias M̂SE CP
400 0 0.25 0.902 0.001 0.001 0.001 0.001 0.949
0.50 1.484 0.003 0.003 0.002 0.003 0.951
1 0.25 0.346 0.000 0.000 0.000 0.000 0.949
0.50 0.790 0.003 0.003 0.002 0.003 0.946
100 0 0.25 0.906 0.006 0.006 0.005 0.006 0.941
0.50 1.489 0.014 0.014 0.007 0.014 0.953
1 0.25 0.347 0.002 0.002 0.001 0.002 0.944
0.50 0.793 0.011 0.011 0.005 0.011 0.943
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Table 4.2.2: One-sample simulation result(α = 2, λ = 0.1875 cause 1 and λ = 0.0625 cause 2)
n t0 τ Qˆ1,t0
̂Avar(Qˆ1,t0)
̂var(Qˆ1,t0) B̂ias M̂SE CP
400 0 0.25 1.277 0.003 0.003 0.004 0.003 0.950
0.50 2.101 0.007 0.007 0.005 0.007 0.949
1 0.25 0.621 0.001 0.001 0.002 0.001 0.945
0.50 1.326 0.006 0.005 0.004 0.005 0.946
100 0 0.25 1.277 0.011 0.011 0.004 0.011 0.945
0.50 2.099 0.028 0.028 0.002 0.028 0.947
1 0.25 0.620 0.004 0.004 0.001 0.004 0.943
0.50 1.324 0.023 0.023 0.001 0.023 0.940
4.2.5 Data Analysis
In Chapter 3, we used death from all causes (breast cancer or non-cancer causes) as the
survival endpoint. The B-04 data set contains information on cause of death (i.e, death due to
breast cancer or non-cancer causes) for each subject. We will use this additional information
to perform breast-cancer related death quantile residual life analysis in the presence of other
causes of death using the proposed method in this chapter. Summary statistics on mortality
and censoring by node status are shown in Table 4.2.3. The mortality rate due to cancer
in the node-positive patients is higher than in the node-negative patients. The mortality
rate due to non-cancer death is lower in the node-positive patients than in the node-negative
patients. The observed censoring proportion in the node positive group is about 0.16, whereas
in the node negative group is about 0.26.
53
Table 4.2.3: Summary statistics on mortality and censoring by node status
Node Event Type n Prop.
Positive Censored 92 0.16
Death (cancer) 332 0.59
Death (non-cancer) 137 0.24
Negative Censored 271 0.26
Death (cancer) 431 0.42
Death (non-cancer) 336 0.32
For the one-sample competing risks quantile residual life analysis, we treated breast cancer
related death as the primary event of interest and non-cancer death as the competing event.
We performed separate analyses for each nodal group. We fitted the Weibull model, where
we assumed that the hazard of death due to each cause could by independently modeled by
the Weibull hazard function. The results for these analyses are shown in Table 4.2.4 for the
node-negative patients and in Table 4.2.5 for the node-positive patients. Each table shows
the point estimate of the quantile residual life for breast cancer related death, the estimate
of the asymptotic variance of the breast cancer-related death quantile residual life, and the
95% confidence interval estimate of the breast cancer-related death quantile residual life at
three time points t0 = 0, 2, 4 and three quantile levels τ = 0.1, 0.2, 0.3. The cause-specific
quantile residual life estimates in Table 4.2.4 and Table 4.2.5 are within reasonable range
of the non-parameteric cause-specific quantile residual life estimates reported in Table 4 of
Jeong and Fine (2013).
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Table 4.2.4: Quantile residual life for cancer-related death, node negative patient
t0 τ Qˆ1,t0
̂Avar(Qˆ1,t0) CILL CIUL
0 0.1 2.827 0.068 2.316 3.338
0.2 6.679 0.221 5.757 7.601
0.3 11.973 0.642 10.403 13.543
2 0.1 3.190 0.031 2.848 3.532
0.2 7.351 0.172 6.538 8.164
0.3 13.188 0.776 11.461 14.915
4 0.1 3.350 0.030 3.012 3.689
0.2 7.721 0.204 6.836 8.606
0.3 13.975 1.060 11.957 15.993
Table 4.2.5: Quantile residual life for non-cancer death, node positive patient
t0 τ Qˆ1,t0
̂Avar(Qˆ1,t0) CILL CIUL
0 0.1 1.070 0.020 0.791 1.349
0.2 2.732 0.075 2.195 3.270
0.3 4.991 0.184 4.152 5.831
2 0.1 1.589 0.009 1.402 1.775
0.2 3.626 0.051 3.181 4.070
0.3 6.304 0.186 5.459 7.149
4 0.1 1.777 0.011 1.572 1.983
0.2 4.018 0.068 3.507 4.529
0.3 6.962 0.263 5.956 7.968
55
4.3 TWO SAMPLE
In this section, we will generalize the result for the one-sample inference in Section 4.2 to the
case of two independent samples. The result presented in this section can be easily extended
to more than two groups. Except for the number of groups, the setting is similar to that of
the one-sample case. In Section 4.3.1 basic results are given. In Section 4.2.4, simulation
results using the Weibulll model are presented, and in Section 4.3.3 proposed method is used
for data analysis.
4.3.1 Theory
The observed data is as follows:
A random sample of competing risks data from population 1, {(X1i, δ1ki)}n1i=1, k=1,2
type of failure. δ1ki = 1 if the failure type is k, and T1i = X1i. Otherwise, δ1ki = 0. If
δ11i = δ12i = 0, then the i
th observation is censored. T1 ∼ F (; θ(1)).
We also have a random sample of competing risks data from population 2, {(X2i, δ2ki)}n2i=1,
k=1,2 type of failure. δ2ki = 1 if the failure type is k, and T2i = X2i. Otherwise, δ2ki = 0. If
δ21i = δ22i = 0, then the i
th observation is censored. T2 ∼ F (; θ(2)). No assumption about the
functional dependency between θ(1) and θ(2) is made. Using the observed data, inference on
the difference between the true cause 1 quantile residual life times of the two populations is
considered,
Q
(1)
1,t0
(τ ; θ(1))−Q(2)1,t0(τ ; θ(2)). (4.3.11)
Likelihood based point and confidence interval estimators are given below. The likelihood for
the observed competing risks data is:
L(θ | {(Xji, δjki)}ni=1, j = 1, 2, k = 1, 2) =
2∏
j=1
nj∏
i=1
f1(Xji; θ
(j))δj1if2(Xji; θ
(j))δj2iS(Xji; θ
(j)),
where θ = (θ(1), θ(2)) is a vector of parameter vectors θ(1) and θ(2) for the distributions of T1i
and T2i, respectively. The joint likelihood (Equation 4.3.11) factorizes into the likelihood
of each group. As a result, the likelihood quantities and inference follow directly from the
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one-sample case. Since the MLEs of θ(1) and θ(2), θˆ(1) and θˆ(1), respectively, are consistent
and the cause-1 quantile residual life of each group are differentiable,
Qˆ
(1)
1,t0
(τ ; θˆ(1))−Q(2)1,t0(τ ; θˆ(2)) (4.3.12)
is a consistent estimator of Q
(1)
1,t0
(τ ; θ(1)) − Q(2)1,t0(τ ; θ(2)). In Equation 4.3.12, the MLE θˆ(1)
and θˆ(1) are estimated separately from each sample.
The asymptotic variance formula for Q
(1)
1,t0
(τ ; θ(1))−Q(2)1,t0(τ ; θ(2)) is:
Avar(Qˆ
(1)
1,t0
) + Avar(Qˆ
(2)
1,t0
) (4.3.13)
where Avar(Qˆ
(j)
t0 )
=
1
nj
{
∇θˆ(j)Q1,t0(τ ; θˆ(j))|θˆ(j)=θ(j)
}T
I−1(θ(j))
{
∇θˆ(j)Qt0(τ ; θˆ(j))|θˆ(j)=θ(j)
}
j = 1, 2
which are consistently estimated using MLEs of θ(1) and θ(2) and the observed information
matrices from the two samples using the same procedure presented in Section 4.2. The results
in Section 4.2 are directly applicable to the two sample situation. MLEs and asymptotic
variance formulas can be derived using the results in Sections 4.2.
4.3.2 Simulation Study
A simulation study was performed to examine the performance of the proposed two-sample
procedure. The simulation was run as in the one-sample case except for the following
differences: two samples were independently generated from the same population at each
simulation run; sample sizes of n = 100 and n = 200 per sample were used.
Simulation results for the two-sample case are presented in Table 4.3.1 and Table 4.3.2.
In each of the tables, the estimated difference in cause 1 quantile residual lifetime( ˆ∆Q1,t0) of
the two groups, estimated asymptotic variance, empirical variance, empirical bias, empirical
MSE, and 95% empirical coverage (CP) are shown.
The simulation results suggest that the proposed method works well for all the simulation
scenarios considered. The asymptotic and Monte Carlo variances are similar to each other
indicating that the model-based asymptotic variance formula performs well. The quantile
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residual life time estimator is unbiased and has small MSE. The empirical coverage probabili-
ties are close to the 95% nominal coverage probability.
Table 4.3.1: Two-sample simulation result, Weibull(α = 2, λ = 0.375 cause 1 and λ = 0.125
cause 2)
n t0 τ ˆ∆Q1,t0
̂Avar(∆Qˆ1,t0)
̂var(∆Qˆ1,t0) B̂ias M̂SE CP
200 0 0.25 0.000 0.006 0.006 0.000 0.006 0.950
0.50 0.001 0.014 0.014 0.001 0.014 0.959
1 0.25 0.000 0.002 0.002 0.000 0.002 0.955
0.50 0.001 0.010 0.010 0.001 0.010 0.960
100 0 0.25 -0.002 0.011 0.011 -0.002 0.011 0.951
0.50 -0.004 0.029 0.028 -0.004 0.028 0.958
1 0.25 -0.001 0.003 0.003 -0.001 0.003 0.951
0.50 -0.003 0.022 0.021 -0.003 0.021 0.961
Table 4.3.2: Two-sample simulation result, Weibull(α = 2, λ = 0.1875 cause 1 and λ = 0.0625
cause 2)
n t0 τ ˆ∆Q1,t0
̂Avar(∆Qˆ1,t0)
̂var(∆Qˆ1,t0) B̂ias M̂SE CP
200 0 0.25 -0.001 0.011 0.011 -0.001 0.011 0.945
0.50 -0.000 0.027 0.027 -0.000 0.027 0.954
1 0.25 0.000 0.004 0.004 0.000 0.004 0.952
0.50 0.001 0.023 0.022 0.001 0.022 0.955
100 0 0.25 0.000 0.022 0.023 0.000 0.023 0.942
0.50 -0.002 0.057 0.058 -0.002 0.058 0.956
1 0.25 -0.001 0.009 0.009 -0.001 0.009 0.948
0.50 -0.003 0.048 0.048 -0.003 0.048 0.962
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4.3.3 Data Analysis
To apply the two-sample result in this section to the B-04 study data, we used nodal status as
a grouping variable and breast cancer-related death as the primary event of interest. Death
from other causes was regarded as the competing event. The difference in the quantile residual
life due to death from breast cancer between the two nodal groups was estimated at three
time points t0 = 0, 2, 4 and three quantile levels τ = 0.1, 0.2, 0.3. The results are shown in
Table 4.3.3. The results indicate that the nodal positive group has a shorter remaining life
time than the nodal negative group for death due to breast-cancer.
Table 4.3.3: Difference in quantile residual life for breast-cancer death between node negative
and node positive patient
t0 τ ˆ∆Q1,t0
̂Avar( ˆ∆Q1,t0) CILL CIUL
0 0.10 1.757 0.088 1.175 2.339
0.20 3.947 0.297 2.879 5.014
0.30 6.982 0.825 5.202 8.762
2 0.10 1.602 0.040 1.212 1.991
0.20 3.725 0.224 2.798 4.652
0.30 6.884 0.962 4.962 8.807
4 0.10 1.573 0.041 1.176 1.969
0.20 3.703 0.272 2.681 4.725
0.30 7.013 1.323 4.758 9.268
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4.4 REGRESSION - ACCELERATED FAILURE TIME MODEL
The goal of this section is to extend the quantile residual inference for the one-sample case to
the regression case while staying within the accelerated failure time (AFT) regression and
the cause-specific hazard modeling framework.
4.4.1 Theory
In competing risks study, in addition to data on failure time and failure type, data on baseline
covariates Z = (Z1, Z2, · · · , Zp) are collected with the object of associating these covariates
to the competing risks process. The effect of covariate Z on the kth cause hazard function
hk(t;Z) can be modelled using AFT model as
hk(t;Z) = h0k{t exp(ZTβk)} exp(ZTβk), (4.4.11)
for k = 1, 2 causes of failure (Prentice et al. (1978)). The kth cause baseline hazard h0k(t)
can be specified as in the case of the one-sample competing risks setting. This model allows
the effect of the covariate to vary by cause.
Consider a random sample of competing risks data {(Xi, δki,Zi)}ni=1, where Zi = (Zi1, Zi2, · · · , Zip)
is the vector of covariates measured on the ith subject. The likelihood based on this competing
risks data is given by
L(θ | {(Xi, δki,Zi)}ni=1) =
n∏
i=1
f1(Xi; θ,Zi)
δ1if2(Xi; θ,Zi)
δ2iS(Xi; θ,Zi)
1−(δ1i+δ2i),
where θ = (θ1, θ2) is the total parameter vector for causes 1 and 2; and θk = (bk, βk) where
bk is a parametric vector for the k
th cause baseline hazard and βk is the regression parameter
vector for the kth-cause hazard function.
Because the parameters for each cause are independent of the parameters of the other
cause, the likelihood factorizes into the likelihood contribution for each cause. Thus, likelihood
quantities (log-likelihood, score vectors, MLEs, and information) for each cause are exactly
as those obtained in the AFT regression model for the non-competing risks setting.
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4.4.2 Computational Issues
Numerical evaluation of the kth cause-specific quantile residual life Qk,t0(τ ; θ,Z) and its
gradient can be obtained by using the procedure in Section 4.2.2 as the covariate Z is known.
Simulation of competing risks data under the AFT assumption can also be performed using
the simulation procedures outlined there.
4.4.3 Application to the Weibull Model
4.4.3.1 Independent shape and scale parameters Under the AFT assumption, the
kth cause-specific cumulative-hazard for the population with covariate Z, H(.;Z), is related
to the kth cause-specific cumulative hazard of baseline population (i.e. the population with
Z = 0) as follows,
Hk(t;Z) =
∫ t
0
h0j
(
u exp
(
ZTβk
))
exp(ZTβk) du
= H0k
(
t exp
(
ZTβk
))
, k = 1, 2.
For the Weibull distribution, we have
H0k
(
t exp
(
ZTβk
))
= λk
(
t exp
(
ZTβk
))αk
= λk exp
(
αkZ
Tβk
)
tαk , k = 1, 2.
Thus, the kth (k = 1, 2) cause-specific cumulative incidence function for the population with
the covariate Z, Fk(t;α1, α2, λ1, λ2,Z), is∫ t
0
exp
(−λ1 exp (α1ZTβ1)uα1 − λ2 exp (α2ZTβ2)uα2)λk exp (αkZTβk)αkuαk−1 du.
(4.4.31)
The kth cumulative incidence function (Equation 4.4.31) does not have a closed form except
in the case of common shape parameter, i.e., α1 = α2 = α. Thus, in the case of independent
shape parameters, the kth quantile residual life time and its gradient should be evaluated
numerically using the procedure discussed in Section 4.2.2.1 and Section 4.2.2.2, respectively.
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The cause 1 quantile residual life for the subject with covariate Z, Qk,t0(τ ;Z) has to be
determined numerically using Equation 4.2.22 where fk(u) and S(to) in the equation are
fk(t;α1, α2, λ1, λ2,Z) = exp
(−λ1 exp (α1ZTβ1)uα1 − λ2 exp (α2ZTβ2)uα2)λj exp (αkZTβk)αkuαk−1,
and
S(t0;α1, α2, λ1, λ2,Z) = exp
(−λ1 exp (α1ZTβ1) tα10 − λ2 exp (α2ZTβ2) tα20 ) .
The gradient of the cause 1 quantile residual life given covariate Z is found using Equa-
tion 4.2.23, where the elements of the gradient of F1(t; .) are
∂F1(t;Z)
∂λ1
=
∫ t
0
α1u
α1−1 [1− λ?1uα1 ] exp(α1ZTβ1) exp(−λ?1uα1 − λ?2uα2) du
∂F1(t;Z)
∂λ2
=
∫ t
0
−λ?1α1uα1+α2−1 exp(α1ZTβ1 + α2ZTβ2) exp(−λ?1uα1 − λ?2uα2) du
∂F1(t;Z)
∂α1
=
∫ t
0
λ?1u
α1−1 (1 + α1 [1− λ?1uα1 ] [ZTβ1 + ln (u)]) exp(−λ?1uα1 − λ?2uα2) du
∂F1(t;Z)
∂α2
=
∫ t
0
−λ?1λ?2
[
ZTβ2 + ln(u)
]
α1u
α1+α2 exp (−λ?1uα1 − λ?2uα2) du
∂F1(t;Z)
∂βk
= λkαk
∂F1(t;Z)
∂λk
Z, k = 1, 2,
and the elements of the gradient of all cause distribution function F (t, .) are,
∂F (u;Z)
∂λk
= uαk exp(αkZ
Tβk) exp(−λ?1uα1 − λ?2uα2)
∂F (u;Z)
∂αk
= λ?k
[
ZTβk + ln(u)
]
uαk exp(−λ?1uα1 − λ?2uα2)
∂F (u;Z)
∂βk
= λkαk
∂F (u;Z)
∂λk
Z, k = 1, 2,
where λ?k = λk exp(αkZ
Tβk), k = 1, 2.
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4.4.3.2 Common shape parameter (α1 = α2) The MLEs for the Weibull-model with
common alpha are obtained by finding the root of the score vector whose elements are,
∂
∂α
`n(θ) =
n∑
i=1
δ1iZ
T
i β1 + (α
−1)
n∑
i=1
δ1i +
n∑
i=1
δ1i ln(Xi) +
n∑
i=1
δ2iZ
T
i β2 + (α
−1)
n∑
i=1
δ2i +
n∑
i=1
δ2i ln(Xi)
−λ1
[
n∑
i=1
Xαi exp(αZ
T
i β1)(Z
T
i β1 + ln(Xi))
]
− λ2
[
n∑
i=1
Xαi exp(αZ
T
i β2)(Z
T
i β2 + ln(Xi))
]
∂
∂λ1
`n(θ) = (λ
−1
1 )
n∑
i=1
δ1i −
n∑
i=1
Xαi exp(αZ
T
i β1)
∂
∂λ2
`n(θ) = (λ
−1
2 )
n∑
i=1
δ2i −
n∑
i=1
Xαi exp(αZ
T
i β2)
∂
∂β1
`n(θ) = α
n∑
i=1
[
δ1i − λ1αXαi exp(αZTi β1)
]
Zi
∂
∂β2
`n(θ) = α
n∑
i=1
[
δ2i − λ2αXαi exp(αZTi β2)
]
Zi.
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The information matrix contains the following entries,
∂2`n
∂2λk
= −λ2k
n∑
i=1
δ1i, k = 1, 2
∂2`n
∂λ1∂λ2
= 0
∂2`n
∂α∂λk
= −
n∑
i=1
(ZTi βk + ln(Xi))X
α
i exp(αZ
T
i βk), k = 1, 2
∂2`n
∂λ1∂β1
= −
n∑
i=1
αXαi exp(αZ
T
i β1)Zi
∂2`n
∂λ2∂β2
= −
n∑
i=1
αXαi exp(αZ
T
i β2)Zi
∂2`n
∂β2∂λ1
=
∂2`n
∂β1∂λ2
= 0
∂2`n
∂β1∂β2
= 0
∂2`n
∂βTk ∂βk
= −
n∑
i=1
λk exp(αZ
T
i β1)α
2Xαi ZiZ
T
i , k = 1, 2
∂2`n
∂α∂βk
= −
n∑
i=1
[
λk exp(αZ
T
i β1)[Z
T
i βk + ln(Xi)]αX
α
i + [δ2i − λk exp(αZTi β1)αXαi ]
]
Zi, k = 1, 2
∂2`n
∂2α
= −α2
n∑
i=1
(δ1i + δ2i)−
n∑
i=1
[λ?1i(Z
T
i β1)
2 + λ?2iZ
T
i β2)
2 + (λ?1i + λ
?
2i)(ln(Xi))
2]Xαi
−2
n∑
i=1
[λ?1iZ
T
i β1 + λ
?
2iZ
T
i β2]X
α
i ln(Xi) where λ
?
ki = λk exp(αZ
T
i βk), k = 1, 2.
The asymptotic variance formula for the estimator of the kth quantile residual life given Z is
given by, {
∇Qˆk,t0(τ ;Z)
}T
I−1(θ)
{
∇Qˆk,t0(τ ;Z)
}
. (4.4.32)
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The gradient of the kth cause quantile residual life given covariate Z, ∇Qˆk,t0(τ ;Z), is found
using Equation 4.2.23, where the elements of the gradient of F1(t; .) in closed form are
∂F1(t;Z)
∂λ1
=
λ?1t
α exp(αZTβ1)
(λ?1 + λ
?
2)
exp(−(λ?1 + λ?2)tα)
∂F1(t;Z)
∂λ2
=
−λ?1 exp(αZTβ2)
(λ?1 + λ
?
2)
2
{1− [1 + (λ?1 + λ?2)tα] exp(−(λ?1 + λ?2)tα)}
∂F1(t;Z)
∂α
=
−λ?1ZT (β1 − β2)
(λ?1 + λ
?
2)
2
[1− exp(−(λ?1 + λ?2)tα)] +
λ?1
λ?1 + λ
?
2
exp(−(λ?1 + λ?2)tα)
{[
λ?1Z
Tβ1 + λ
?
2Z
Tβ2
]
tα + (λ?1 + λ
?
2)t
α ln(t)
}
∂F1(t;Z)
∂β1
= αλ1
∂F1(t;Z)
∂λ1
Z
∂F1(t;Z)
∂β2
= αλ2
∂F1(t;Z)
∂λ2
Z,
and the elements of the gradient of all cause distribution function F (t, .) in closed form are,
∂F (u;Z)
∂λ1
= uα exp(αZTβ1) exp(−(λ?1 + λ?2)uα)
∂F (u;Z)
∂λ2
= uα exp(αZTβ2) exp(−(λ?1 + λ?2)uα)
∂F (u;Z)
∂α
= λ?1
[
ZTβ1 + ln(u)
]
uα exp(−(λ?1 + λ?2)uα) +
λ?2
[
ZTβ2 + ln(u)
]
uα exp(−(λ?1 + λ?2)uα)
∂F (u;Z)
∂β1
= αλ1
∂F (u;Z)
∂λ1
Z
∂F (u;Z)
∂β2
= αλ2
∂F (u;Z)
∂λ2
Z,
where λ?k = λk exp(αZ
Tβk), k = 1, 2.
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4.4.4 Simulation Study
Simulation Method 2 was used to generate competing risks data from the Weibull AFT regre-
sion model with common shape parameter α where we used (α1, λ1, β11, β12) = (2, 1, 0.2, 0.15)
for cause 1 and (α2, λ2, β21, β22) = (2, 0.5,−0.15, 0.2) for cause 2. We simulated a binary covari-
ate Z1 from Bernoulli(0.5) distribution and a continuous covariate Z2 from the the standard
normal distribution. Two time points t0 = 0, 1, two quantile levels τ = 0.1, 0.3, and a sample
size of n = 200 were used. The censoring proportion was set at 0.3, where censoring times were
generated from uniform distributions. 5000 data sets were generated at each simulation setting.
The true cause 1 quantile residual life at Z = (0, 0), Z = (1, 0), Z = (0, 1), andZ = (0, 0)
were used to investigate the performance of the proposed procedure. The coverage probability
(CP) is for 95% confidence intervals.
The results in Table 4.4.1 suggest that coverage probability is close to the nominal 95%
coverage level for all simulation settings. The Monte Carlo variance is also similar to the
asymptotic variance indicating that the model-based asymptotic variance formula works well
under the simulation settings considered. The cause 1 quantile residual life estimator is
unbiased.
66
Table 4.4.1: AFT competing risks regression, common shape parameter
(Z1, Z2) t0 τ ̂Avar(Q1,t0)
̂var(Qˆ1,t0) B̂ias CP
(0, 0) 0 0.10 0.001 0.001 -0.006 0.949
1 0.000 0.000 0.000 0.929
0 0.30 0.003 0.003 -0.006 0.954
1 0.001 0.001 0.000 0.931
(1, 0) 0 0.10 0.001 0.001 -0.003 0.947
1 0.000 0.000 0.000 0.931
0 0.30 0.002 0.002 -0.002 0.948
1 0.000 0.000 0.001 0.930
(0, 1) 0 0.10 0.001 0.001 -0.006 0.945
1 0.000 0.000 -0.000 0.929
0 0.30 0.004 0.004 -0.008 0.952
1 0.001 0.001 -0.002 0.928
(1, 1) 0 0.10 0.001 0.001 -0.004 0.948
1 0.000 0.000 0.000 0.930
0 0.30 0.002 0.002 -0.004 0.952
1 0.000 0.000 0.001 0.932
4.4.5 Data Analysis
For data analyses, we modeled the cause-specific hazards due to each cause (cancer and
non-caner death) independently using the Weibull model. We used the variables node (a
binary variable), age and tumor size as covariates for AFT Weibull regression modeling. Age
and tumor size were centered around their overall means before the analyses. The baseline
distribution is that of the node-positive patient at the mean age and mean tumor size.
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    The results in Table 4.4.2 indicate that bigger tumor size and positive node status
significantly increase the hazard of death from breast cancer, whereas higher baseline age 
significantly increases the hazard of death from non-cancer causes. Higher baseline age 
increases non-significantly the hazard of death from cancer, and positive node status and 
bigger tumor size increase non-significantly the hazard of death from non-cancer causes.
Table 4.4.2: Parameter estimates for the cause-specific Weibull hazard functions
Cause of death α λ Node Age Tumor Size
Cancer 0.869(0.027) 0.085(0.007) -0.673(0.085) 0.002(0.004)* 0.009(0.002)
Non-cancer 1.468(0.055) 0.006(0.001) -0.04(0.069)* 0.042(0.003) 0.002(0.002)*
*Non-significant at 0.05 significance level. Standard errors are given in parentheses.
For cause-specific quantile residual life analyses, we used breast-cancer death as the main
event and non-cancer death as the competing event. Quantile residual life times for death
from cancer were estimated for node positive patient at the median age (55 yrs) and tumor
size (32 mm), and node negative patient at the median age (57 yrs) and tumor size (30 mm).
The results in Table 4.4.3 and Table 4.4.4 are consistent with the results obtained for the
one-sample analyses.
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Table 4.4.3: Quantile residual life for death due to cancer for node negative with median age
and tumor size
t0 τ Qˆ1,t0
̂Avar(Qˆ1,t0) CILL CIUL
0 0.10 2.638 0.192 1.779 3.497
0.20 6.461 1.083 4.422 8.501
0.30 11.829 4.174 7.825 15.833
2 0.10 3.191 0.190 2.336 4.046
0.20 7.460 1.203 5.311 9.610
0.30 13.597 5.448 9.022 18.172
4 0.10 3.433 0.206 2.543 4.324
0.20 8.013 1.369 5.721 10.306
0.30 14.784 6.994 9.600 19.967
Table 4.4.4: Quantile residual life for death due to cancer for node positive patient with
median age and tumor size
t0 τ Qˆ1,t0
̂Avar(Qˆ1,t0) CILL CIUL
0 0.10 1.315 0.016 1.067 1.563
0.20 3.151 0.062 2.661 3.640
0.30 5.512 0.162 4.723 6.300
2 0.10 1.683 0.010 1.488 1.878
0.20 3.765 0.052 3.316 4.213
0.30 6.400 0.170 5.591 7.208
4 0.10 1.819 0.011 1.613 2.025
0.20 4.045 0.061 3.560 4.530
0.30 6.870 0.210 5.972 7.767
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5.0 SUMMARY
In this dissertation, we proposed a parametric inference for quantile residual life for one-sample,
two-sample and regression cases under both competing and non-competing risks settings. For
the competing risks set-up, we adopted a cause-specific hazard modeling approach, where the
hazard function for each cause is independently parameterized.
While this modeling approach is flexible, it raises computational challenges that have not
been identified and addressed in the existing parametric competing risks literature. The main
computational problems were lack of closed form expression for the cause-specific quantile
residual life and its gradient, and the difficulty of simulating competing risks data. We
proposed numerical solutions for determining the cause-specific quantile residual life and its
gradient, and derived an asymptotic variance formula for the estimator of the cause-specific
quantile residual life time. We also suggested a simulation procedure for generating competing
risks data under the cause-specific hazard modeling approach.
We investigated the performance of the proposed procedures using simulation studies.
The simulation results indicated that the proposed procedures work well. We applied the
proposed methods to analyze a breast cancer survival data.
We used the Weibull model for both simulation and data analyses. We chose this model
for illustration because it is a simple and flexible model. Under ideal circumstance, alternative
models should be compared for their appropriateness for the application on hand.
70
BIBLIOGRAPHY
Beyersmann, Jan, Aurelien Latouche, Anika Buchholz, and Martin Schumacher (2009),
“Simulating competing risks data in survival analysis.” Statistics in Medicine, 28, 956–971.
Boos, Dennis D and LA Stefanski (2013), “Large sample theory: The basics.” In Essential
Statistical Inference, 207–274, Springer.
Borgan, Ørnulf (1984), “Maximum likelihood estimation in parametric counting process
models, with applications to censored failure time data.” Scandinavian Journal of Statistics,
1–16.
Casella, George and CP Robert (2004), “Monte carlo statistical methods.” Springer&Verlag,
New York.
Fisher, Bernard, Jong-Hyeon Jeong, Stewart Anderson, John Bryant, Edwin R Fisher, and
Norman Wolmark (2002), “Twenty-five-year follow-up of a randomized trial comparing
radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.” New
England Journal of Medicine, 347, 567–575.
Fisher, Bernard, Eleanor Montague, Carol Redmond, Bruce Barton, Donna Borland, Edwin R
Fisher, Melvin Deutsch, George Schwarz, Richard Margolese, William Donegan, et al. (1977),
“Comparison of radical mastectomy with alternative treatments for primary breast cancer: a
first report of results from a prospective randomized clinical trial.” Cancer, 39, 2827–2839.
Jeong, J. H. and J. P. Fine (2013), “Nonparametric inference on cause-specific quantile
residual life.” Biom J, 55, 68–81.
Jeong, J-H and JP Fine (2009), “A note on cause-specific residual life.” Biometrika, 96,
237–242.
Jeong, Jong-Hyeon and Jason Fine (2006), “Direct parametric inference for the cumulative
incidence function.” Journal of the Royal Statistical Society: Series C (Applied Statistics),
55, 187–200.
Jeong, Jong-Hyeon and Jason P Fine (2007), “Parametric regression on cumulative incidence
function.” Biostatistics, 8, 184–196.
71
Jeong, Jong-Hyeon, Sin-Ho Jung, and Joseph P Costantino (2008), “Nonparametric inference
on median residual life function.” Biometrics, 64, 157–163.
Jung, Sin-Ho, Jong-Hyeon Jeong, and Hanna Bandos (2009), “Regression on quantile residual
life.” Biometrics, 65, 1203–1212.
Kalbfleisch, John D and Ross L Prentice (2002), The statistical analysis of failure time data,
volume 360. John Wiley & Sons.
Kay, Richard and Nelson Kinnersley (2002), “On the use of the accelerated failure time model
as an alternative to the proportional hazards model in the treatment of time to event data:
a case study in influenza.” Drug information journal, 36, 571–579.
Klein, John P and Melvin L Moeschberger (2003), Survival analysis: techniques for censored
and truncated data. Springer Science & Business Media.
Koenker, Roger and Gilbert Bassett (1978), “Regression quantiles.” Econometrica: journal
of the Econometric Society, 33–50.
Lagakos, SW (1979), “General right censoring and its impact on the analysis of survival data.”
Biometrics, 139–156.
Lee, Minjung and Jason P Fine (2011), “Inference for cumulative incidence quantiles via
parametric and nonparametric approaches.” Statistics in medicine, 30, 3221–3235.
Lin, DY and CF Spiekerman (1996), “Model checking techniques for parametric regression
with censored data.” Scandinavian journal of statistics, 157–177.
Ng, SK and GJ McLachlan (2003), “An em-based semi-parametric mixture model approach
to the regression analysis of competing-risks data.” Statistics in Medicine, 22, 1097–1111.
Patel, Katie, Richard Kay, and Lucy Rowell (2006), “Comparing proportional hazards and
accelerated failure time models: an application in influenza.” Pharmaceutical statistics, 5,
213–224.
Prentice, Ross L, John D Kalbfleisch, Arthur V Peterson Jr, Nancy Flournoy, VT Farewell,
and NE Breslow (1978), “The analysis of failure times in the presence of competing risks.”
Biometrics, 541–554.
Shi, Haiwen, Yu Cheng, and Jong-Hyeon Jeong (2013), “Constrained parametric model for
simultaneous inference of two cumulative incidence functions.” Biometrical Journal, 55,
82–96.
Wei, LJ (1992), “The accelerated failure time model: a useful alternative to the cox regression
model in survival analysis.” Statistics in medicine, 11, 1871–1879.
72
